B4GALT1

UniProt ID: P15291
Organism: Homo sapiens
Review Status: DRAFT
📝 Provide Detailed Feedback

Gene Description

B4GALT1 encodes beta-1,4-galactosyltransferase 1 (beta4Gal-T1; CAZy family GT7), a type II single-pass membrane glycosyltransferase resident in the trans-Golgi cisternae. Its luminal catalytic domain transfers galactose from UDP-alpha-D-galactose in a beta-1,4 linkage onto the non-reducing terminal N-acetylglucosamine (GlcNAc) of complex-type N-glycans, of O-glycans, and of glycolipids, forming the Galbeta1-4GlcNAc (type-2 N-acetyllactosamine, LacNAc) unit that is the scaffold for further glycan extension (sialylation, fucosylation, poly-LacNAc). It requires Mn2+ as cofactor. The same catalytic activity, applied to several distinct acceptors, underlies its multiple EC assignments (EC 2.4.1.38 on GlcNAc of glycoproteins; EC 2.4.1.90 on free GlcNAc to make LacNAc; EC 2.4.1.275 on glycolipids). The enzyme is uniquely bifunctional: in the lactating mammary gland it forms a 1:1 complex with alpha-lactalbumin (LALBA) called lactose synthase, in which alpha-lactalbumin lowers the Km for glucose and switches the acceptor specificity from GlcNAc to glucose, so the complex synthesizes lactose (Galbeta1-4Glc; EC 2.4.1.22), the major milk sugar. A distinct longer isoform bearing a 13-residue N-terminal cytoplasmic extension is preferentially delivered to the cell surface, where galactosyltransferase has been proposed to act as a cell-cell and cell-matrix recognition molecule (including as a sperm receptor for ZP3); a proteolytically processed soluble form is found in milk, amniotic fluid and serum. The dominant physiological state, however, is the Golgi-resident enzyme. Loss-of-function and hypomorphic variants cause congenital disorder of glycosylation type IId (CDG2D), and a hypomorphic missense allele (p.Asn352Ser) lowers serum LDL-cholesterol and fibrinogen by reducing their N-glycan galactosylation.

Proposed New Ontology Terms

lactose synthase complex

Definition: A heterodimeric protein-containing complex, located in the Golgi membrane of lactating mammary epithelial cells, composed of beta-1,4-galactosyltransferase 1 (the catalytic subunit) and alpha-lactalbumin (the regulatory subunit). Within this complex alpha-lactalbumin alters the acceptor specificity of beta-1,4-galactosyltransferase 1 from N-acetylglucosamine to glucose, enabling the synthesis of lactose from UDP-galactose and glucose.

Justification: B4GALT1 has a long-established, structurally characterized obligate complex with alpha-lactalbumin (lactose synthase; PMID:11419947), but the only complex term applied in GOA is the uninformative top-level GO:0032991 (protein-containing complex). A specific CC term for the lactose synthase complex would let B4GALT1 (and LALBA) be annotated to their actual functional complex via in_complex rather than the generic parent.

Parent term: protein-containing complex

Mappings:

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005794 Golgi apparatus
IBA
GO_REF:0000033 		ACCEPT
Summary: Phylogenetically inferred Golgi residence for the GT7 family. This is the correct core compartment: B4GALT1 is a trans-Golgi resident type II membrane enzyme (codistributes with thiamine pyrophosphatase in trans-Golgi cisternae, PMID:6121819; IDA Golgi PMID:7744867). is_active_in is appropriate. Accept as a core location (the more granular Golgi membrane / Golgi trans cisterna terms are also present and preferred for specificity).
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IBA
GO_REF:0000033 		ACCEPT
Summary: Phylogenetically inferred core catalytic activity, concordant with extensive direct experimental evidence (PMID:16157350 crystal structures + kinetics; multiple EXP/IDA annotations). This is the central, evolutionarily conserved molecular function of B4GALT1. Accept as core.
GO:0006487 protein N-linked glycosylation
IBA
GO_REF:0000033 		ACCEPT
Summary: Core biological process: B4GALT1 performs the galactosylation step of complex N-glycan maturation, adding Gal to terminal GlcNAc of N-glycan antennae (directly assayed in PMID:16157350; IgG Fc N-glycan galactosylation PMID:27872474). Accept as a core process.
GO:0000139 Golgi membrane
IEA
GO_REF:0000117 		ACCEPT
Summary: Electronic (ARBA) Golgi membrane location, consistent with the experimentally established trans-Golgi membrane residence of this type II membrane enzyme. Correct and specific; accept as core location.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IEA
GO_REF:0000120 		ACCEPT
Summary: Electronic assignment (RHEA:22932 / EC 2.4.1.38) of the core catalytic activity, redundant with the experimentally supported IBA/IDA/EXP annotations to the same term. Correct; accept.
GO:0003945 N-acetyllactosamine synthase activity
IEA
GO_REF:0000120 		ACCEPT
Summary: Electronic assignment (RHEA:17745 / EC 2.4.1.90) of the activity transferring Gal to free GlcNAc to make LacNAc. Experimentally supported (IDA PMID:16157350, PMID:33805, PMID:2120039) and a genuine facet of the core activity. Accept.
GO:0004461 lactose synthase activity
IEA
GO_REF:0000120 		ACCEPT
Summary: Electronic assignment (RHEA:12404 / EC 2.4.1.22) of the lactose synthase activity that B4GALT1 acquires in complex with alpha-lactalbumin. Experimentally supported (EXP PMID:11419947, PMID:806951; IDA PMID:33805) and a core, evolutionarily selected bifunctional activity. Accept.
GO:0005576 extracellular region
IEA
GO_REF:0000044 		KEEP AS NON CORE
Summary: Electronic mapping from the UniProt "Secreted" keyword for the processed soluble form (shed catalytic domain found in milk/amniotic fluid/serum, PMID:33805). Real but a minor, processed-form location, not the core Golgi enzyme. Keep as non-core.
GO:0005886 plasma membrane
IEA
GO_REF:0000120 		KEEP AS NON CORE
Summary: Electronic plasma-membrane mapping reflecting the cell-surface long isoform (PMID:1714903; PMID:3917437). A genuine but specialized/non-core pool relative to the Golgi catalytic function. Keep as non-core.
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002 		MARK AS OVER ANNOTATED
Summary: Very high-level InterPro-derived process term. Not wrong, but uninformative for an enzyme whose specific processes (protein N-linked glycosylation, lactose biosynthesis, glycolipid/oligosaccharide biosynthesis) are well defined and already annotated. Over-annotation at this generality.
GO:0009986 cell surface
IEA
GO_REF:0000120 		KEEP AS NON CORE
Summary: Electronic cell-surface mapping for the long isoform's surface pool (PMID:1714903; PMID:3917437). Genuine but specialized; keep as non-core.
GO:0016757 glycosyltransferase activity
IEA
GO_REF:0000002 		MODIFY
Summary: Broad InterPro grandparent term. The specific beta-1,4-galactosyltransferase activity (GO:0003831) is experimentally established and should supersede this generic term.
GO:0030175 filopodium
IEA
GO_REF:0000044 		MARK AS OVER ANNOTATED
Summary: Electronic mapping from a UniProt subcellular-location keyword associated with the cell-surface form. There is no direct evidence for a dedicated B4GALT1 filopodial function; this is an over-extension of the surface/recognition pool annotation.
GO:0032580 Golgi cisterna membrane
IEA
GO_REF:0000044 		ACCEPT
Summary: Electronic Golgi cisterna membrane location, consistent with the trans-Golgi cisternal residence demonstrated by immuno-EM (PMID:6121819). Correct and specific; accept as a core location.
GO:0005794 Golgi apparatus
IEA
GO_REF:0000107 		ACCEPT
Summary: Ensembl-Compara orthology-based Golgi apparatus location, redundant with the IBA/IDA Golgi annotations. Correct core compartment. Accept.
GO:0008378 galactosyltransferase activity
IEA
GO_REF:0000107 		MODIFY
Summary: Parent term (galactosyltransferase activity) inferred by orthology. The specific beta-1,4-galactosyltransferase activity is experimentally established; modify to the specific child.
GO:0032991 protein-containing complex
IEA
GO_REF:0000107 		MARK AS OVER ANNOTATED
Summary: Uninformative top-level complex term inferred by orthology. The biologically meaningful complex for B4GALT1 is the lactose synthase complex (with LALBA); there is also the homodimer/tubulin association (PMID:7744867). No specific GO CC term for the lactose synthase complex currently exists (see proposed_new_terms), so this generic term should be treated as an over-annotation rather than left as is.
GO:0005989 lactose biosynthetic process
TAS
Reactome:R-HSA-5653890 		ACCEPT
Summary: Reactome traceable annotation for lactose synthesis. B4GALT1, in the lactose synthase complex, is the catalytic component producing lactose in lactating mammary gland (PMID:11419947; PMID:806951). This is a genuine, tissue-specific core process. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
TAS
Reactome:R-HSA-3656230 		ACCEPT
Summary: Reactome reaction ("Defective B4GALT1 does not transfer Gal to the keratan chain") annotating the core galactosyltransferase activity (here in the keratan sulfate context). Correct core MF. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
TAS
Reactome:R-HSA-4793956 		ACCEPT
Summary: Reactome reaction ("Defective B4GALT1 does not add Gal to N-glycan") annotating the core N-glycan galactosyltransferase activity. Correct core MF. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
TAS
Reactome:R-HSA-9035949 		ACCEPT
Summary: Reactome reaction annotating the core galactosyltransferase activity (N-glycan precursor context). Redundant with the other MF annotations; correct. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
TAS
Reactome:R-HSA-9035950 		ACCEPT
Summary: Reactome reaction annotating the core galactosyltransferase activity (keratan branch context). Correct core MF. Accept.
GO:0004461 lactose synthase activity
EXP
PMID:11419947
Crystal structure of lactose synthase reveals a large confor... 		ACCEPT
Summary: Direct experimental support: crystal structures of the lactose synthase complex (beta4Gal-T1 + alpha-lactalbumin) showing alpha-lactalbumin switches acceptor specificity to glucose to make lactose. Core bifunctional activity. Accept.
Supporting Evidence:
PMID:11419947
The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component, beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component, alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to synthesize lactose
GO:0004461 lactose synthase activity
EXP
PMID:806951
Lactose biosynthesis. 		ACCEPT
Summary: Experimental support for lactose synthase activity (lactose biosynthesis review/ primary work). Concordant with the structural and biochemical evidence; core. Accept.
GO:0005794 Golgi apparatus
IDA
GO_REF:0000052 		ACCEPT
Summary: Human Protein Atlas immunofluorescence (IDA) localizing B4GALT1 to the Golgi apparatus. Concordant with all other localization evidence. Core. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
EXP
PMID:29133956
Network inference from glycoproteomics data reveals new reac... 		ACCEPT
Summary: Experimental demonstration of B4GALT1 galactosylation in the IgG glycosylation pathway (network inference plus enzymatic validation). Supports the core MF on complex N-glycans. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
EXP
PMID:37632720
Divergent Enzymatic Assembly of a Comprehensive 64-Membered ... 		ACCEPT
Summary: Experimental use of B4GALT1 to galactosylate defined IgG N-glycans in a synthetic glycan library. Direct support for the core galactosyltransferase activity on N-glycan acceptors. Accept.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
EXP
PMID:38321209
Immobilized enzyme cascade for targeted glycosylation. 		ACCEPT
Summary: Experimental demonstration of B4GALT1 galactosyltransferase activity in an immobilized enzyme cascade for targeted N-glycosylation. Core MF. Accept.
GO:0003945 N-acetyllactosamine synthase activity
EXP
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase... 		ACCEPT
Summary: Crystallographic and kinetic study of human beta4Gal-T1 with GlcNAc-containing acceptors, directly demonstrating transfer of Gal to GlcNAc (LacNAc synthesis) and branch specificity. Core MF. Accept.
Supporting Evidence:
PMID:16157350
beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked oligosaccharide chains of glycoproteins
GO:0004461 lactose synthase activity
EXP
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase... 		ACCEPT
Summary: Same structural/kinetic study addressing the acceptor specificity that underlies lactose synthase activity (EC 2.4.1.22 listed in UniProt with this PMID as evidence). Core bifunctional activity. Accept.
GO:0005576 extracellular region
NAS
PMID:2120039
Analysis of the substrate binding sites of human galactosylt... 		KEEP AS NON CORE
Summary: Non-traceable author statement; this paper engineered/secreted a soluble form of the enzyme in E. coli for substrate-site mapping, consistent with the known soluble shed form found extracellularly (PMID:33805). Minor processed-form location; keep as non-core.
GO:0005886 plasma membrane
EXP
PMID:1714903
Evidence for a molecular distinction between Golgi and cell ... 		KEEP AS NON CORE
Summary: Experimental evidence that the long isoform (extra 13-aa N-terminal cytoplasmic peptide) is preferentially targeted to the plasma membrane, distinct from the Golgi short form. A genuine but specialized surface pool; keep as non-core.
Supporting Evidence:
PMID:1714903
the longer GalTase protein, containing this unique 13-amino acid peptide, is preferentially targeted to the plasma membrane, and the shorter GalTase protein resides primarily within the Golgi compartment
GO:0009986 cell surface
EXP
PMID:1714903
Evidence for a molecular distinction between Golgi and cell ... 		KEEP AS NON CORE
Summary: Same study supporting the surface-targeted long isoform. Surface pool is specialized (cell-cell/cell-matrix recognition), not the core catalytic compartment. Keep as non-core.
GO:0061755 positive regulation of circulating fibrinogen levels
IMP
PMID:34855475
Genetic and functional evidence links a missense variant in ... 		KEEP AS NON CORE
Summary: Based on the hypomorphic p.Asn352Ser allele that lowers plasma fibrinogen by reducing fibrinogen N-glycan galactosylation/sialylation. This is a downstream, indirect physiological consequence of reduced core galactosyltransferase activity, not a dedicated regulatory process of B4GALT1. Keep as non-core (the underlying mechanism is the core MF, already captured).
Supporting Evidence:
PMID:34855475
The mutant protein had 50% lower galactosyltransferase activity compared with the wild-type protein. N-linked glycan profiling of human serum found serine 352 allele to be associated with decreased galactosylation and sialylation of apolipoprotein B100, fibrinogen, immunoglobulin G, and transferrin
GO:0006629 lipid metabolic process
IMP
PMID:34855475
Genetic and functional evidence links a missense variant in ... 		MARK AS OVER ANNOTATED
Summary: Derived from the same allele's effect on LDL-cholesterol, via reduced galactosylation of ApoB100 (a glycoprotein), an indirect/downstream consequence. B4GALT1 is a glycosyltransferase, not a lipid-metabolic enzyme; the lipid phenotype is a secondary effect of altered glycoprotein glycosylation. Over-annotation as a direct process.
Supporting Evidence:
file:human/B4GALT1/B4GALT1-deep-research-falcon.md
The reviewed literature supports protein N-glycosylation and galactosylation as core constitutive functions, while roles in cancer cell migration, apoptosis, and inflammatory signaling represent context-specific, pleiotropic consequences
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IMP
PMID:34855475
Genetic and functional evidence links a missense variant in ... 		ACCEPT
Summary: The p.Asn352Ser mutant shows ~50% reduced galactosyltransferase activity, providing mutant-phenotype support that B4GALT1 enables this activity. Core MF. Accept.
GO:0035250 UDP-galactosyltransferase activity
IMP
PMID:34855475
Genetic and functional evidence links a missense variant in ... 		MODIFY
Summary: Parent-level term (UDP-galactosyltransferase activity). The specific beta-1,4-galactosyltransferase activity is the experimentally established function; modify to the specific child.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IDA
PMID:27872474
Multi-level glyco-engineering techniques to generate IgG wit... 		ACCEPT
Summary: Direct assay: B4GALT1 used to galactosylate IgG Fc N-glycans in a glyco-engineering study. Supports the core MF. Accept.
GO:0005794 Golgi apparatus
IDA
PMID:7744867
Golgi retention mechanism of beta-1,4-galactosyltransferase.... 		ACCEPT
Summary: Direct localization plus mechanism: transmembrane-domain-dependent homodimerization and tubulin association mediate Golgi retention. Core Golgi location. Accept.
Supporting Evidence:
PMID:7744867
beta-1,4-galactosyltransferase (GT) forms homodimers and large oligomers in vivo
GO:0030667 secretory granule membrane
TAS
Reactome:R-HSA-6798743 		KEEP AS NON CORE
Summary: Reactome neutrophil-degranulation pathway annotation. Reflects presence of B4GALT1 in granule-membrane proteomes during exocytosis rather than a core functional location. Keep as non-core.
GO:0035577 azurophil granule membrane
TAS
Reactome:R-HSA-6798739 		KEEP AS NON CORE
Summary: Reactome neutrophil azurophil-granule annotation, from large-scale granule proteomics. Not a core functional compartment for the galactosyltransferase. Keep as non-core.
GO:0070062 extracellular exosome
HDA
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expres... 		KEEP AS NON CORE
Summary: High-throughput exosome proteomics (prostatic secretions). Consistent with the shed/ secreted soluble form, but exosome detection is a common high-throughput finding and not the core Golgi location. Keep as non-core.
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells. 		MARK AS OVER ANNOTATED
Summary: Trivial "membrane" location from an NK-cell membrane-proteome dataset. The protein is a single-pass membrane enzyme so "membrane" is true but uninformative; the specific Golgi membrane terms supersede it. Over-annotation.
GO:0005576 extracellular region
HDA
PMID:16502470
Human colostrum: identification of minor proteins in the aqu... 		KEEP AS NON CORE
Summary: Detection in human colostrum proteome (high-throughput). Consistent with the soluble secreted form in milk (PMID:33805); a minor processed-form location, not core. Keep as non-core.
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IDA
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase... 		ACCEPT
Summary: Direct crystallographic + kinetic demonstration of Gal transfer from UDP-Gal to GlcNAc on N-glycan acceptors, with branch specificity. The single best primary evidence for the core MF. Accept.
Supporting Evidence:
PMID:16157350
the K(m) of 1,2-1,6-arm is approximately tenfold lower than for 1,2-1,3-arm and 1,4-1,3-arm
GO:0006487 protein N-linked glycosylation
IDA
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase... 		ACCEPT
Summary: Direct-assay support for B4GALT1's role in N-glycan maturation (galactosylation of N-glycan antennae). Core process. Accept.
GO:0030145 manganese ion binding
IDA
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase... 		ACCEPT
Summary: B4GALT1 is a metal-dependent GT-A fold glycosyltransferase crystallized with Mn2+ in the active site; Mn2+ is required for catalysis. Direct, core cofactor-binding function. Accept.
GO:0070062 extracellular exosome
HDA
PMID:19199708
Proteomic analysis of human parotid gland exosomes by multid... 		KEEP AS NON CORE
Summary: High-throughput parotid exosome proteomics. As with the other exosome detections, a non-core location consistent with the secreted/shed form. Keep as non-core.
GO:0070062 extracellular exosome
HDA
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exos... 		KEEP AS NON CORE
Summary: High-throughput urinary exosome proteomics. Non-core location (secreted/shed form). Keep as non-core.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-3656230 		ACCEPT
Summary: Reactome places the (defective) keratan-galactosylation reaction at the Golgi membrane. Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-4793956 		ACCEPT
Summary: Reactome Golgi membrane location for the N-glycan galactosylation reaction. Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-9035949 		ACCEPT
Summary: Reactome Golgi membrane location (N-glycan precursor reaction). Correct core location, redundant with the other Golgi membrane annotations. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-9035950 		ACCEPT
Summary: Reactome Golgi membrane location (keratan branch reaction). Correct core location. Accept.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-1297338 		KEEP AS NON CORE
Summary: Reactome annotation for "Association of ADAM and B4GALT1 With ZP3" (fertilization / sperm-egg binding), placing the surface form at the plasma membrane. Reflects the specialized cell-surface recognition role of the long isoform. Keep as non-core.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-6798739 		KEEP AS NON CORE
Summary: Reactome neutrophil-degranulation pathway (plasma-membrane fusion of azurophil granules). Non-core trafficking location. Keep as non-core.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-6798743 		KEEP AS NON CORE
Summary: Reactome secretory-granule exocytosis pathway. Non-core trafficking location. Keep as non-core.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-2025723 		ACCEPT
Summary: Reactome Golgi membrane location ("B4GALTs transfer Gal to the N-glycan precursor"). Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-2046265 		ACCEPT
Summary: Reactome Golgi membrane location ("B4GALTs transfer Gal to the keratan chain"). Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-2046298 		ACCEPT
Summary: Reactome Golgi membrane location ("B4GALTs transfer Gal to a branch of keratan"). Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-5653878 		ACCEPT
Summary: Reactome Golgi membrane location for "B4GALT1:LALBA transfers Gal from UDP-Gal to Glc to form Lac" (lactose synthesis occurs in the Golgi). Correct core location. Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-5653886 		ACCEPT
Summary: Reactome Golgi membrane location for "B4GALT1 binds LALBA". Correct core location (lactose synthase assembly in the Golgi). Accept.
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-975919 		ACCEPT
Summary: Reactome Golgi membrane location ("Addition of galactose by beta 4-galactosyltransferases"). Correct core location. Accept.
GO:0003945 N-acetyllactosamine synthase activity
IDA
PMID:2120039
Analysis of the substrate binding sites of human galactosylt... 		ACCEPT
Summary: Protein-engineering/mutagenesis study of recombinant human galactosyltransferase mapping the GlcNAc and UDP-Gal binding residues (Tyr284, Tyr309, Trp310). Directly supports the core LacNAc-synthase activity. Accept.
Supporting Evidence:
PMID:2120039
Tyr284, Tyr309 and Trp310 are critically involved in the N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as well
GO:0005794 Golgi apparatus
IDA
PMID:10900002
Localization of alpha 1,3-fucosyltransferase VI in Weibel-Pa... 		ACCEPT
Summary: Immunolocalization study (Weibel-Palade bodies / endothelial cells) using B4GALT1 as a Golgi marker; supports Golgi localization. Core location. Accept.
GO:0009312 oligosaccharide biosynthetic process
IDA
PMID:2120039
Analysis of the substrate binding sites of human galactosylt... 		KEEP AS NON CORE
Summary: Process annotation for oligosaccharide (LacNAc) biosynthesis. Not wrong, but relatively general; the specific processes (protein N-linked glycosylation, lactose biosynthesis, glycosphingolipid biosynthesis) are better captured by more precise terms. Keep as non-core (broad correct process).
GO:0000138 Golgi trans cisterna
IDA
PMID:6121819
Immunocytochemical localization of galactosyltransferase in ... 		ACCEPT
Summary: Immuno-EM directly localizing galactosyltransferase to two-to-three trans cisternae of the Golgi, codistributing with thiamine pyrophosphatase. This is the most specific, experimentally supported core sub-Golgi location. Accept.
Supporting Evidence:
PMID:6121819
Label by gold particles was limited to two to three trans cisternae of the Golgi apparatus
GO:0003831 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
IDA
PMID:33805
The charge heterogeneity of soluble human galactosyltransfer... 		ACCEPT
Summary: Purified soluble human galactosyltransferase from milk/amniotic fluid/ascites shows Gal transfer to GlcNAc/glycoprotein acceptors. Direct support for the core MF (the soluble form retains activity). Accept.
Supporting Evidence:
PMID:33805
UDP-galactose: N-acetylglucosamine galactosyltransferase was isolated from pooled human milk, pooled amniotic fluid and from two different individual samples of malignant ascites
GO:0003945 N-acetyllactosamine synthase activity
IDA
PMID:33805
The charge heterogeneity of soluble human galactosyltransfer... 		ACCEPT
Summary: Same purified enzyme assayed with free N-acetylglucosamine acceptor (LacNAc synthesis). Direct support for the core LacNAc-synthase facet. Accept.
Supporting Evidence:
PMID:33805
All enzyme forms showed similar activity when free N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
GO:0004461 lactose synthase activity
IDA
PMID:33805
The charge heterogeneity of soluble human galactosyltransfer... 		ACCEPT
Summary: Same enzyme assayed with glucose acceptor in the presence of alpha-lactalbumin (lactose synthase activity). Direct support for the core bifunctional activity. Accept.
Supporting Evidence:
PMID:33805
glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
GO:0009897 external side of plasma membrane
IDA
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransfera... 		KEEP AS NON CORE
Summary: Immuno-EM of human duodenal enterocytes showing ecto-galactosyltransferase preferentially oriented to the outer surface of the plasma membrane. Genuine surface (ecto) pool; specialized/non-core relative to the Golgi catalytic role. Keep as non-core.
Supporting Evidence:
PMID:3917437
Quantitative evaluation of the distribution of gold-particle label proved its preferential orientation to the outer surface of the plasma membrane
GO:0016323 basolateral plasma membrane
IDA
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransfera... 		KEEP AS NON CORE
Summary: Same study: basolateral/lateral membrane labeling of enterocytes, with a proposed adhesion role. Surface pool; non-core.
Supporting Evidence:
PMID:3917437
a role in adhesion appears possible on the basolateral plasma membrane
GO:0030057 desmosome
IDA
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransfera... 		MARK AS OVER ANNOTATED
Summary: Labeling near junctional complexes in enterocytes. This is incidental immuno-EM localization of the surface pool to junctional regions, not evidence of a dedicated desmosomal function of B4GALT1. Over-annotation.
GO:0031526 brush border membrane
IDA
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransfera... 		KEEP AS NON CORE
Summary: Intense brush-border-membrane labeling of absorptive enterocytes (ecto-GalT). A genuine apical surface pool in this cell type; specialized/non-core. Keep as non-core.
Supporting Evidence:
PMID:3917437
the most intense labeling appearing along the brush border membrane
GO:0035250 UDP-galactosyltransferase activity
IDA
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransfera... 		MODIFY
Summary: Parent-level activity term inferred from ecto-GalT enzymatic detection. The specific beta-1,4-galactosyltransferase activity is established; modify to the specific child.
GO:0009312 oligosaccharide biosynthetic process
NAS
PMID:7540104
Analysis of the sequences of human beta-1,4-galactosyltransf... 		KEEP AS NON CORE
Summary: Non-traceable author statement (cDNA cloning paper). Broad but correct process; the specific glycosylation/lactose processes are better captured elsewhere. Keep as non-core (general correct process).
GO:0008378 galactosyltransferase activity
NAS
PMID:7540104
Analysis of the sequences of human beta-1,4-galactosyltransf... 		MODIFY
Summary: Parent term from a cDNA-cloning NAS annotation. Replace with the specific experimentally established beta-1,4-galactosyltransferase activity.

Core Functions

Core catalytic function: B4GALT1 is a Mn2+-dependent, trans-Golgi-resident type II membrane glycosyltransferase that transfers galactose from UDP-alpha-D-galactose in a beta-1,4 linkage onto the non-reducing terminal N-acetylglucosamine of complex-type N-glycans (and of glycolipids and free GlcNAc), forming the Galbeta1-4GlcNAc (type-2 LacNAc) unit. This is the galactosylation step of complex N-glycan maturation and the LacNAc-synthesis activity, requiring Mn2+ as cofactor.

Molecular Function:
beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
Directly Involved In:
protein N-linked glycosylation
Cellular Locations:
Golgi membrane Golgi trans cisterna
Substrates:
UDP-alpha-D-galactose
Supporting Evidence:
  • PMID:16157350
    beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked oligosaccharide chains of glycoproteins
  • PMID:6121819
    Label by gold particles was limited to two to three trans cisternae of the Golgi apparatus

LacNAc synthase facet of the core activity: transfer of Gal from UDP-Gal to free or terminal GlcNAc to form N-acetyllactosamine (Galbeta1-4GlcNAc), the universal scaffold for further glycan extension (poly-LacNAc, sialylation, fucosylation). Mn2+-dependent.

Molecular Function:
N-acetyllactosamine synthase activity
Cellular Locations:
Golgi membrane
Supporting Evidence:
  • PMID:2120039
    Tyr284, Tyr309 and Trp310 are critically involved in the N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as well
  • PMID:33805
    All enzyme forms showed similar activity when free N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates

Bifunctional lactose synthase activity: in the lactating mammary gland B4GALT1 forms a 1:1 complex with alpha-lactalbumin (LALBA). alpha-Lactalbumin lowers the Km for glucose and switches the acceptor specificity from GlcNAc to glucose, so the complex transfers Gal from UDP-Gal to glucose to synthesize lactose (Galbeta1-4Glc), the major milk sugar. This is a tissue-specific, evolutionarily selected core function executed at the Golgi membrane.

Molecular Function:
lactose synthase activity
Directly Involved In:
lactose biosynthetic process
Cellular Locations:
Golgi membrane
Supporting Evidence:
  • PMID:11419947
    The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component, beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component, alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to synthesize lactose

Cofactor binding required for catalysis: B4GALT1 is a GT-A fold, metal-dependent glycosyltransferase that binds Mn2+ in its active site, coordinating the UDP-Gal diphosphate for galactosyl transfer.

Molecular Function:
manganese ion binding
Cellular Locations:
Golgi membrane
Supporting Evidence:
  • PMID:16157350
    beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues

References

GO_REF:0000002
Gene Ontology annotation through association of InterPro records with GO terms
GO_REF:0000033
Annotation inferences using phylogenetic trees
GO_REF:0000044
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
GO_REF:0000052
Gene Ontology annotation based on curation of immunofluorescence data
GO_REF:0000107
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
GO_REF:0000117
Electronic Gene Ontology annotations created by ARBA machine learning models
GO_REF:0000120
Combined Automated Annotation using Multiple IEA Methods
PMID:10900002
Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells.
PMID:11419947
Crystal structure of lactose synthase reveals a large conformational change in its catalytic component, the beta1,4-galactosyltransferase-I.
  • Lactose synthase is a 1:1 complex of beta4Gal-T1 (catalytic) and alpha-lactalbumin (regulatory); alpha-lactalbumin promotes glucose binding and switches acceptor specificity from GlcNAc to glucose, enabling lactose synthesis.
    "The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component, beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component, alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to synthesize lactose"
PMID:16157350
Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety.
  • Human beta4Gal-T1 transfers Gal from UDP-Gal to terminal GlcNAc of branched N-glycan chains, with preference for the 1,2-1,6-arm GlcNAc.
    "beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked oligosaccharide chains of glycoproteins"
PMID:16502470
Human colostrum: identification of minor proteins in the aqueous phase by proteomics.
PMID:1714903
Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase.
  • The longer isoform with a 13-aa N-terminal cytoplasmic extension is preferentially targeted to the plasma membrane; the shorter isoform resides in the Golgi.
    "the longer GalTase protein, containing this unique 13-amino acid peptide, is preferentially targeted to the plasma membrane, and the shorter GalTase protein resides primarily within the Golgi compartment"
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exosomes.
PMID:19199708
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
PMID:19946888
Defining the membrane proteome of NK cells.
PMID:2120039
Analysis of the substrate binding sites of human galactosyltransferase by protein engineering.
  • Mutagenesis of recombinant human galactosyltransferase identifies Tyr284, Tyr309 and Trp310 as critical for GlcNAc binding, and Tyr309 for UDP-galactose binding.
    "Tyr284, Tyr309 and Trp310 are critically involved in the N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as well"
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
PMID:27872474
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.
  • B4GALT1 is used to galactosylate IgG Fc N-glycans; galactosylation level can be modulated by glyco-engineering, supporting the enzyme's role in complex N-glycan galactosylation.
    "glycosyltransferases were transiently overexpressed to enhance bisection, galactosylation and sialylation"
PMID:29133956
Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway.
PMID:33805
The charge heterogeneity of soluble human galactosyltransferases isolated from milk, amniotic fluid and malignant ascites.
  • Soluble human UDP-galactose:GlcNAc galactosyltransferase purified from milk, amniotic fluid and ascites is active on free GlcNAc, glycoprotein acceptors and on glucose in the presence of alpha-lactalbumin.
    "All enzyme forms showed similar activity when free N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates"
  • The enzyme exists as a soluble shed form in body fluids.
    "UDP-galactose: N-acetylglucosamine galactosyltransferase was isolated from pooled human milk, pooled amniotic fluid and from two different individual samples of malignant ascites"
PMID:34855475
Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen.
  • The hypomorphic p.Asn352Ser allele halves galactosyltransferase activity and lowers serum LDL-C and fibrinogen by reducing galactosylation/sialylation of ApoB100, fibrinogen, IgG and transferrin.
    "The mutant protein had 50% lower galactosyltransferase activity compared with the wild-type protein. N-linked glycan profiling of human serum found serine 352 allele to be associated with decreased galactosylation and sialylation of apolipoprotein B100, fibrinogen, immunoglobulin G, and transferrin"
PMID:37632720
Divergent Enzymatic Assembly of a Comprehensive 64-Membered IgG N-Glycan Library for Functional Glycomics.
PMID:38321209
Immobilized enzyme cascade for targeted glycosylation.
PMID:3917437
Immunocytochemical demonstration of ecto-galactosyltransferase in absorptive intestinal cells.
  • Ecto-galactosyltransferase is present on the plasma membrane of human duodenal enterocytes, most intensely on the brush border, oriented to the outer surface, with a possible adhesion role basolaterally.
    "Antigenic sites detected with affinity-purified, monospecific antibodies were found at the plasma membrane of absorptive enterocytes with the most intense labeling appearing along the brush border membrane"
PMID:6121819
Immunocytochemical localization of galactosyltransferase in HeLa cells: codistribution with thiamine pyrophosphatase in trans-Golgi cisternae.
  • Galactosyltransferase is localized to two-to-three trans cisternae of the Golgi, codistributing with thiamine pyrophosphatase.
    "Label by gold particles was limited to two to three trans cisternae of the Golgi apparatus"
PMID:7540104
Analysis of the sequences of human beta-1,4-galactosyltransferase cDNA clones.
PMID:7744867
Golgi retention mechanism of beta-1,4-galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins.
  • B4GALT1 forms transmembrane-domain-dependent homodimers/oligomers and associates with alpha- and beta-tubulin, mechanisms underlying its Golgi retention.
    "beta-1,4-galactosyltransferase (GT) forms homodimers and large oligomers in vivo"
PMID:806951
Lactose biosynthesis.
file:human/B4GALT1/B4GALT1-deep-research-falcon.md
FutureHouse Falcon deep-research report for B4GALT1
  • Deep-research synthesis: core function is Golgi (trans-Golgi) beta-1,4-galactosylation of terminal GlcNAc to form LacNAc on N-glycans/glycolipids, with Mn2+ cofactor and UDP-Gal donor; lactose synthase (with LALBA) is a tissue-specific core function; reported cancer/apoptosis/inflammation roles are pleiotropic, context-specific consequences of altered glycosylation and not dedicated B4GALT1 processes.
    "The reviewed literature supports protein N-glycosylation and galactosylation as core constitutive functions, while roles in cancer cell migration, apoptosis, and inflammatory signaling represent context-specific, pleiotropic consequences"
Reactome:R-HSA-1297338
Association of ADAM and B4GALT1 With ZP3
Reactome:R-HSA-2025723
B4GALTs transfer Gal to the N-glycan precursor
Reactome:R-HSA-2046265
B4GALTs transfer Gal to the keratan chain
Reactome:R-HSA-2046298
B4GALTs transfer Gal to a branch of keratan
Reactome:R-HSA-3656230
Defective B4GALT1 does not transfer Gal to the keratan chain
Reactome:R-HSA-4793956
Defective B4GALT1 does not add Gal to N-glycan
Reactome:R-HSA-5653878
B4GALT1:LALBA transfers Gal from UDP-Gal to Glc to form Lac
Reactome:R-HSA-5653886
B4GALT1 binds LALBA
Reactome:R-HSA-5653890
Lactose synthesis
Reactome:R-HSA-6798739
Exocytosis of azurophil granule membrane proteins
Reactome:R-HSA-6798743
Exocytosis of secretory granule membrane proteins
Reactome:R-HSA-9035949
Defective B4GALT1 does not transfer Gal to the N-glycan precursor
Reactome:R-HSA-9035950
Defective B4GALT1 does not transfer Gal to a branch of keratan
Reactome:R-HSA-975919
Addition of galactose by beta 4-galactosyltransferases

Suggested Questions for Experts

Q: Beyond the well-established Golgi catalytic role and the lactose synthase complex, does the cell-surface (long isoform) pool of B4GALT1 have a physiologically significant galactosyltransferase or recognition function in humans (e.g. sperm-egg ZP3 binding or cell-matrix adhesion), or is this largely a feature inferred from mouse orthologs?

Q: What is the relative in vivo contribution of B4GALT1 versus the other B4GALT family members (B4GALT2-4) to the bulk galactosylation of complex N-glycans, O-glycans, keratan sulfate and glycolipids in different human tissues?

Suggested Experiments

Experiment: Glycomic/glycoproteomic profiling of B4GALT1-knockout versus wild-type human cells (and rescue with catalytically dead vs wild-type B4GALT1) to quantify loss of terminal Galbeta1-4GlcNAc on N-glycans, O-glycans and glycolipids and to define which acceptor classes are most dependent on B4GALT1 versus redundant family members.

Hypothesis: B4GALT1 is the dominant but partially redundant beta-1,4-galactosyltransferase for complex N-glycan LacNAc formation, with acceptor-class-specific dependence.

Experiment: Reconstitution of the lactose synthase complex with purified B4GALT1 and LALBA, measuring the alpha-lactalbumin-dependent shift in acceptor Km (glucose vs GlcNAc), to quantify the regulatory switch and test how disease/variant residues (e.g. the Asn352Ser hypomorph) affect both N-glycan galactosylation and lactose synthesis.

Hypothesis: alpha-Lactalbumin binding lowers the glucose Km of B4GALT1 by orders of magnitude, and hypomorphic variants reduce both LacNAc and lactose synthesis proportionally to their effect on the shared catalytic site.

Experiment: Isoform-resolved localization and functional assay (CRISPR knock-in of tags on the long vs short B4GALT1 isoforms) in polarized epithelial cells to determine whether the surface long-isoform pool carries out extracellular galactosylation or acts purely as a non-catalytic recognition molecule.

Hypothesis: The long isoform's cell-surface pool functions chiefly in cell-surface recognition/adhesion rather than as a major source of extracellular galactosyltransfer.

Deep Research

Falcon

(B4GALT1-deep-research-falcon.md)
Gene Research for GO Annotation Review Falcon

Gene Research for GO Annotation Review

Target

  • Gene symbol: B4GALT1
  • Organism: Homo sapiens

UniProt Context

=== UNIPROT METADATA ===
UniProt ID: P15291
Entry Name: B4GT1_HUMAN
Gene Name: B4GALT1
Protein Name: Beta-1,4-galactosyltransferase 1
EC Number: 2.4.1.275
Organism: Homo sapiens (Human)
NCBI Taxonomy ID: 9606
Function: [Processed beta-1,4-galactosyltransferase 1]: The secreted form is proficient in galactosyltransferase activity and could be involved in glycan remodeling in biological fluids.
Subcellular Location: [Processed beta-1,4-galactosyltransferase 1]: Secreted
Subunit: Homodimer; and heterodimer with LALBA/alpha-lactalbumin to form lactose synthase. Interacts (via N-terminal cytoplasmic domain) with UBE2Q1 (via N-terminus); the interaction is direct (By similarity).
======================

Research Objective

Prepare a comprehensive literature-backed research report for GO annotation review of the target gene.

Focus on:

  1. The core biochemical activity of the gene product and any substrate specificity.
  2. The activation or maturation mechanism of the protein, including proteolytic processing if relevant.
  3. The best-supported subcellular localization and complexes where the active protein functions.
  4. The strongest experimentally supported biological processes in the target organism, or in very close orthologs when transfer is justified.
  5. Which annotations appear to reflect core function versus context-specific, pleiotropic, or over-extended roles.
  6. Any evidence bearing on apoptosis, developmental cell death, neuronal roles, inflammatory signaling, pyroptosis, synaptic remodeling, protein processing, and localization to cytoplasm, cytosol, nucleus, or signaling complexes.

Output Requirements

Structure the report as:

  1. Executive summary
  2. Molecular function
  3. Biological process roles
  4. Cellular localization and complexes
  5. Annotation-risk assessment
  6. Key literature

Use citations for all substantive claims.

Comprehensive Research Report for GO Annotation Review: B4GALT1 (Homo sapiens)

Executive Summary

Beta-1,4-galactosyltransferase 1 (B4GALT1) is a well-characterized Golgi-resident glycosyltransferase (EC 2.4.1.275) that catalyzes the transfer of galactose from UDP-galactose to terminal N-acetylglucosamine residues on glycoproteins, forming β1,4-linked galactose structures essential for complex N-glycan maturation (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). The protein functions primarily as a type II transmembrane protein localized to the trans-Golgi apparatus, where its luminal catalytic domain executes galactosylation reactions (yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). In lactating mammary epithelium, B4GALT1 forms the lactose synthase complex with alpha-lactalbumin (LALBA), redirecting activity toward glucose to produce lactose (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). The reviewed literature supports protein N-glycosylation and galactosylation as core constitutive functions, while roles in cancer cell migration, apoptosis, and inflammatory signaling represent context-specific, pleiotropic consequences of altered glycosylation in disease states rather than primary biological processes (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2).

1. Molecular Function

1.1 Core Biochemical Activity

B4GALT1 encodes beta-1,4-galactosyltransferase 1, a member of the β1,4-galactosyltransferase family (EC 2.4.1.275) that catalyzes the transfer of galactose in β1,4 linkage from the nucleotide sugar donor UDP-galactose (UDP-Gal) to acceptor molecules (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). This activity represents the fundamental biochemical function of the enzyme across tissues.

Aspect Summary Evidence/Citation
Gene / protein B4GALT1 encodes beta-1,4-galactosyltransferase 1 (β4GalT1), a Golgi-resident glycosyltransferase in the β1,4-galactosyltransferase family. Reviews describe B4GALT1 as a glycosyltransferase involved in Golgi glycosylation and as a type II membrane protein class member (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)
Core enzymatic activity Catalyzes transfer of galactose in β1,4 linkage from UDP-galactose to suitable acceptors; in mammary gland, the same catalytic machinery forms lactose synthase with LALBA. B4GalT1 is described as a galactosyltransferase using UDP-Gal in Golgi glycosylation; lactose synthesis reviews identify B4GALT1 as the catalytic component of lactose synthase (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, slater2025glycosyltransferasesglycoengineersin pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)
EC number EC 2.4.1.275. Matches the target/UniProt metadata supplied for the reviewed gene product; recent inhibitor and functional papers discuss the same catalytic target B4GALT1 (xu2025discoveryofcompound pages 1-2, wiertelak2025cytosolicudpgalbiosynthetic pages 1-2)
Sugar donor UDP-galactose (UDP-Gal) is the direct donor substrate. Multiple papers explicitly state that B4GALT1 function depends on UDP-Gal availability in the Golgi lumen and interacts functionally with the UDP-Gal transporter SLC35A2 (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)
Cofactor requirement Mn²⁺ is a canonical cofactor for β4-galactosyltransferase activity in lactose/HMO biosynthesis schemes. HMO/lactose synthesis review notes B4GALT1 catalytic activity in this biosynthetic context with Mn²⁺ as cofactor (slater2025glycosyltransferasesglycoengineersin pages 1-2, sadovnikova2021acomparativereview pages 1-3)
Major acceptor class: N-glycans on glycoproteins Principal acceptors are terminal N-acetylglucosamine (GlcNAc) residues on N-glycans of glycoproteins, producing β1,4-galactosylated termini during complex N-glycan maturation. B4GALT1 is described as crucial for complex-type N-glycan formation and galactosylation; AD and HCC papers connect B4GALT1 expression with increased N-glycan galactosylation (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, chen2023decreasedb4galt1promotes pages 1-2, tang2023transcriptomicandglycomic pages 1-2)
Specific glycoprotein acceptors observed in human cells Experimentally supported substrates include integrin α6 and integrin β1 in hepatocellular carcinoma cells, whose N-glycans are modified by B4GALT1. Mass spectrometry and lectin pull-down assays identified integrin α6/β1 as main B4GALT1 substrates in HCC cells (chen2023decreasedb4galt1promotes pages 1-2)
Other acceptor contexts Galactose-bearing glycans generated by B4GALT1 also support lectin interactions, e.g., galectin-8 binding to B4GALT1-dependent glycans on TGFBR2/TβRII in CRC. CRC study shows anti-migratory galectin-8 effect depends on B4GALT1-mediated N-glycosylation of TGF-β receptor context (hsu2024b4galt1dependentgalectin8binding pages 1-2)
Glycolipid-related scope Family reviews note β1,4-galactosyltransferases can act in glycoprotein and glycolipid biosynthesis broadly, but for B4GALT1, the strongest direct support in the reviewed set is for glycoprotein N-glycan galactosylation, not a core glycolipid-specific role. Functional and disease papers emphasize N-glycan galactosylation; glycolipid-specialized activities are discussed more prominently for other B4GALT family members (chen2023decreasedb4galt1promotes pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)
Main glycan products Generates terminal Galβ1-4GlcNAc structures, i.e., type 2 N-acetyllactosamine (LacNAc) units on glycoproteins. AD study explicitly states B4GALT1 adds terminal galactose to N-glycans to generate type 2 LacNAc units; platelet/megakaryocyte study links increased B4GALT1 to higher LacNAc expression (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2)
Product in lactose synthesis In complex with α-lactalbumin (LALBA), B4GALT1 transfers galactose to glucose to produce lactose. Lactose synthesis review identifies B4GALT1 + LALBA as the lactose synthase complex in the Golgi of mammary epithelial cells (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2)
Functional consequence of product formation Formation of galactosylated N-glycans modulates receptor/integrin behavior, adhesion, migration, and lectin binding rather than acting as a signaling enzyme per se. HCC and CRC studies show altered B4GALT1-dependent galactosylation changes integrin-mediated laminin adhesion and galectin-8/TGFBR2 interactions (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2)
Catalytic pocket / active-site pharmacology Small-molecule inhibitor work supports a UDP-galactose-binding catalytic pocket, with reported ligand contacts including Arg187 and Glu313 in a modeled/experimental inhibition framework. Selective inhibitor study for B4GALT1 describes binding in the UDP-Gal pocket and provides pharmacologic support for the catalytic site model (xu2025discoveryofcompound pages 1-2)
Alternative names Common names include beta-1,4-galactosyltransferase 1, β4GalT1 / B4GalT1, and historically UDP-galactose:β-N-acetylglucosamine β1,4-galactosyltransferase 1; in lactation context it is the catalytic component of lactose synthase. Nomenclature and family context are consistent across glycosylation and lactose synthesis reviews (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)
Protein form / isoform note The reviewed literature consistently discusses the canonical Golgi type II membrane form; a soluble/secreted form can arise by proteolytic shedding rather than representing a distinct catalytically redefined isoform in the core function literature surveyed. Golgi-resident type II topology is emphasized in reviews; SPPL3-mediated intramembrane proteolysis explains release of soluble Golgi enzymes including B4GALT1-related secretion context (hobohm2022nterminomeanalysesunderscore pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2)

Table: This table summarizes the best-supported molecular-function features of human B4GALT1 for GO review, including catalytic activity, substrates, products, donor/cofactor requirements, EC assignment, and naming/isoform considerations.

1.2 Substrate Specificity

The primary physiological acceptors for B4GALT1 are terminal N-acetylglucosamine (GlcNAc) residues on N-linked glycans of glycoproteins, where the enzyme generates Galβ1-4GlcNAc structures, also known as type 2 N-acetyllactosamine (LacNAc) units (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). Recent experimental evidence identified specific glycoprotein substrates in human hepatocellular carcinoma cells, including integrin α6 and integrin β1, whose N-glycans are modified by B4GALT1 (chen2023decreasedb4galt1promotes pages 1-2). Mass spectrometry-based approaches and lectin pull-down assays confirmed these integrins as major protein substrates, demonstrating that B4GALT1-dependent galactosylation modulates integrin function and cell-matrix interactions (chen2023decreasedb4galt1promotes pages 1-2).

In colorectal cancer cells, B4GALT1-dependent galactosylation of the TGF-β type II receptor (TGFBR2) supports binding of galectin-8, a galactose-binding lectin, which competes with TGF-β for receptor engagement (hsu2024b4galt1dependentgalectin8binding pages 1-2). This illustrates how B4GALT1 activity creates glycan structures that enable lectin-glycan recognition events with downstream functional consequences.

1.3 Cofactors and Catalytic Mechanism

B4GALT1 requires UDP-galactose as the immediate sugar donor substrate (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). The enzyme's dependence on luminal UDP-Gal delivery is supported by evidence that B4GALT1 functionally interacts with the Golgi UDP-galactose transporter SLC35A2, and that disruption of cytosolic UDP-Gal biosynthesis impairs both SLC35A2 dimerization and its interaction with B4GALT1 (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2). Mn²⁺ serves as a canonical cofactor for β1,4-galactosyltransferase activity, particularly in lactose and human milk oligosaccharide biosynthetic contexts (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2).

Structure-based inhibitor studies targeting B4GALT1 identified a UDP-galactose-binding catalytic pocket with key residues including Arg187 and Glu313, providing pharmacologic validation of the active site architecture (xu2025discoveryofcompound pages 1-2). These findings support the enzyme's mechanism as a glycosyltransferase utilizing a nucleotide sugar donor in a stereospecific transfer reaction.

1.4 Products and Functional Consequences

The principal product of B4GALT1 activity on glycoproteins is terminal Galβ1-4GlcNAc (LacNAc) structures (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2). Transcriptomic and glycomic analyses in Alzheimer's disease brain tissue demonstrated that upregulation of B4GALT1 gene expression correlates with increased concentrations of corresponding galactosylated N-glycans, supporting a direct link between enzyme expression and glycan product formation (tang2023transcriptomicandglycomic pages 1-2). Similarly, studies of myeloproliferative neoplasms found that increased B4GALT1 expression in megakaryocytes associates with elevated LacNAc expression on platelet surfaces (buduo2021increasedb4galt1expression pages 1-2).

In mammary epithelial cells during lactation, B4GALT1 forms the lactose synthase complex with alpha-lactalbumin (LALBA), which redirects the enzyme's acceptor specificity from GlcNAc to glucose, resulting in lactose (Galβ1-4Glc) production (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). This tissue-specific modulation of B4GALT1 activity represents a well-characterized example of how regulatory protein interactions can alter glycosyltransferase substrate preference.

2. Protein Processing and Activation Mechanisms

2.1 Proteolytic Processing and Secretion

While B4GALT1 functions primarily as a Golgi-resident type II transmembrane protein, evidence supports the existence of a secreted, processed form generated through proteolytic shedding (hobohm2022nterminomeanalysesunderscore pages 1-2). N-terminome analyses of isogenic SPPL3-deficient cell lines identified B4GALT1 in cell culture supernatants and demonstrated that soluble Golgi enzyme secretion occurs through SPPL3-mediated intramembrane proteolysis (hobohm2022nterminomeanalysesunderscore pages 1-2). This processing mechanism releases Golgi glycosyltransferases from their membrane anchor, enabling their secretion into extracellular fluids.

The transmembrane domain of glycosyltransferases can determine susceptibility to SPPL3 cleavage, and chimeric construct experiments support the role of the transmembrane region in dictating protease substrate recognition (hobohm2022nterminomeanalysesunderscore pages 1-2). The secreted form of B4GALT1, as noted in UniProt metadata, is described as proficient in galactosyltransferase activity and may be involved in glycan remodeling in biological fluids, though the physiological significance of this secreted activity remains less well-defined than the Golgi-resident form's role in cellular glycosylation.

Survey of public proteome data confirms that SPPL3 cleavage products of Golgi enzymes, including those related to B4GALT1 processing, are present in human blood, supporting the in vivo relevance of this proteolytic processing pathway (hobohm2022nterminomeanalysesunderscore pages 1-2).

3. Cellular Localization and Protein Complexes

3.1 Subcellular Localization

B4GALT1 is best supported as a Golgi apparatus-localized glycosyltransferase, with strongest evidence placing it in the trans-Golgi or late Golgi compartment of mammalian cells (yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). Three-dimensional super-resolution imaging studies using structured illumination microscopy employed B4GALT1 as a reference trans-Golgi marker among N-glycan-modifying enzymes, demonstrating its defined positioning within the Golgi ribbon (yagi2024decipheringthesubgolgi pages 1-2). Reviews of Golgi trafficking and glycosylation likewise classify B4GALT1 alongside other trans-Golgi enzymes such as ST6GAL1 (maszczakseneczko2022deliveryofnucleotide pages 1-2).

Aspect Finding Evidence GO annotation implication
Best-supported localization B4GALT1 is best supported as a Golgi-resident glycosyltransferase, with strongest evidence placing it in the trans-Golgi / late Golgi of mammalian cells. 3D super-resolution imaging study uses B4GALT1 as a trans-Golgi marker among N-glycan-modifying enzymes; Golgi trafficking reviews likewise classify B4GALT1 with trans-Golgi enzymes such as ST6GAL1 (yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Strong support for Golgi apparatus and more specifically trans-Golgi localization as the core cellular component annotation.
Golgi sub-compartment distribution Sub-Golgi distribution is not generic across glycosyltransferases; B4GALT1 shows defined positioning shaped by its N-terminal CTS region and is repeatedly used as a reference enzyme for the trans side of the Golgi. Yagi et al. found CTS regions determine sub-Golgi localization and included B4GALT1 as a trans-Golgi reference; morphology review notes B4GALT1 as a positional marker for trans-Golgi analyses (yagi2024decipheringthesubgolgi pages 1-2) Supports trans-Golgi network/trans-Golgi cisterna-level interpretation where GO granularity allows, though plain Golgi apparatus remains safest.
Membrane topology B4GALT1 belongs to the classical Golgi glycosyltransferase architecture: type II single-pass membrane protein with short N-terminal cytosolic tail, transmembrane segment, stem region, and luminal catalytic domain. Reviews of Golgi glycosyltransferases and nucleotide-sugar delivery describe B4GALT1-class enzymes as type II membrane proteins with luminal catalytic domains; SPPL3 study reiterates Golgi glycan-modifying enzymes are membrane-anchored via N-terminal TMD and type II topology (hobohm2022nterminomeanalysesunderscore pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2, chatterjee2023centralroleof pages 1-2) Strong support for a membrane-anchored Golgi enzyme; argues against default annotation to free cytosol/cytoplasm.
Catalytic-side orientation The catalytic domain functions in the Golgi lumen, consistent with use of luminal UDP-galactose supplied by SLC35A2. UDP-Gal transport review and Wiertelak et al. emphasize that glycosyltransferase catalytic domains, including B4GALT1, reside in the ER/Golgi lumen and depend on luminal nucleotide sugar import (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Supports Golgi lumen-facing catalytic activity but not a soluble cytosolic enzyme annotation.
Lactose synthase complex In mammary epithelium, B4GALT1 forms the lactose synthase complex with alpha-lactalbumin (LALBA); this complex redirects acceptor specificity toward glucose to produce lactose. Lactose synthesis reviews state the lactose synthase complex is formed by B4GALT1 and LALBA in the Golgi and catalyzes joining glucose and UDP-galactose to form lactose (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2) Supports protein-containing complex annotation for lactose synthase complex, but this is tissue/context-specific rather than universal across all cells.
Interaction with UDP-Gal transporter machinery B4GALT1 interacts with the UDP-galactose transporter SLC35A2 in the Golgi membrane, linking donor supply to glycosyltransferase organization. Wiertelak et al. showed SLC35A2 can interact with B4GALT1 and that perturbing cytosolic UDP-Gal biosynthesis diminishes this interaction (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2) Supports a Golgi membrane glycosylation machinery complex concept, though not necessarily a stable named complex for direct GO complex annotation.
Other complex/organization evidence B4GALT1 localization and function fit broader Golgi enzyme-retention networks governed by Golgi trafficking determinants and CTS-based positioning. Reviews discuss B4GALT1 as part of the organized Golgi glycosylation machinery, with trafficking/retention mechanisms maintaining enzyme placement across Golgi cisternae (yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Good support for Golgi residency; weaker support for assigning membership in a specific stable multiprotein complex beyond lactose synthase.
Secreted/processed form A soluble secreted form of B4GALT1 is supported by evidence that Golgi enzymes can be released from their membrane anchor; B4GALT1 is detected in supernatants in the context of Golgi enzyme shedding. Hobohm et al. identified widespread SPPL3-mediated intramembrane proteolysis of Golgi enzymes and discuss B4GALT1 in culture supernatants/membrane fractions in the framework of Golgi enzyme secretion (hobohm2022nterminomeanalysesunderscore pages 1-2) Supports annotation to a secreted, processed form only if the annotation system distinguishes processed products; should not replace core Golgi localization of the full-length enzyme.
Processing mechanism The secretion mechanism is best explained as proteolytic shedding following intramembrane cleavage, mediated broadly by SPPL3 for Golgi-resident enzymes. SPPL3 study demonstrates intramembrane proteolysis as a physiological route for secretion of Golgi enzymes and emphasizes TMD-dependent susceptibility of glycosyltransferases (hobohm2022nterminomeanalysesunderscore pages 1-2) Supports GO notes on protein processing/proteolysis-dependent secretion, but evidence for B4GALT1-specific cleavage details is less direct than for some other substrates.
Alternative localization: plasma membrane Only limited indirect discussion exists for glycosyltransferases reaching post-Golgi sites or plasma membrane; this appears to reflect trafficking escape/shedding paradigms rather than a core functional localization for B4GALT1. General glycosyltransferase trafficking literature notes Golgi enzymes can escape to post-Golgi compartments/plasma membrane, but the reviewed B4GALT1 evidence base still centers on Golgi residency (hobohm2022nterminomeanalysesunderscore pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Do not prioritize plasma membrane localization for core B4GALT1 annotation without stronger direct B4GALT1-specific evidence.
Alternative localization: cytoplasm/cytosol No strong evidence from the reviewed literature supports B4GALT1 as a functional cytosolic enzyme. Its N-terminus faces cytosol, but catalytic activity is luminal. Type II membrane topology places only a short tail in cytosol; catalytic function is Golgi luminal and donor usage depends on luminal substrate delivery (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Avoid cytosol/cytoplasm as active-site localization in GO except insofar as membrane topology implies a short cytosolic tail.
Alternative localization: nucleus No reviewed evidence supports nuclear localization or nuclear complex membership for B4GALT1. The retrieved literature consistently describes B4GALT1 in Golgi glycosylation contexts and does not provide nuclear localization data (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) No support for nucleus-related annotation.
Overall annotation confidence The most robust model is: full-length B4GALT1 is a type II trans-Golgi glycosyltransferase; a context-dependent processed soluble form can be secreted; and a specialized Golgi complex with LALBA forms lactose synthase in mammary cells. Convergent support from imaging, trafficking, glycosylation, and lactose synthesis literature (sadovnikova2021acomparativereview pages 1-3, wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, yagi2024decipheringthesubgolgi pages 1-2, hobohm2022nterminomeanalysesunderscore pages 1-2, slater2025glycosyltransferasesglycoengineersin pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Core GO terms should emphasize Golgi/trans-Golgi, type II membrane glycosyltransferase, and lactose synthase complex only where the tissue context is appropriate.

Table: This table summarizes the strongest evidence for where B4GALT1 functions in the cell and which complexes or processing states are experimentally supported. It is useful for distinguishing core Golgi-localized functions from context-specific complexes and processed secreted forms.

The enzyme adopts a classical type II transmembrane protein topology, comprising a short N-terminal cytosolic tail, a single transmembrane domain, a stem region, and a C-terminal luminal catalytic domain (hobohm2022nterminomeanalysesunderscore pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). This architecture orients the catalytic machinery toward the Golgi lumen, where it accesses UDP-galactose delivered by nucleotide sugar transporters and acts on glycoprotein substrates trafficking through the secretory pathway (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2).

Evidence from sub-Golgi distribution studies indicates that the N-terminal CTS (cytoplasmic-transmembrane-stem) region determines precise sub-Golgi localization, and artificially swapping CTS regions between glycosyltransferases can alter their colocalization patterns (yagi2024decipheringthesubgolgi pages 1-2). This supports a model wherein B4GALT1's trans-Golgi positioning reflects retention mechanisms mediated by its structural domains rather than simple passive distribution.

3.2 Protein Complexes

Lactose Synthase Complex: The best-characterized protein complex involving B4GALT1 is the lactose synthase complex, formed in mammary epithelial cells through interaction with alpha-lactalbumin (LALBA) (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). In this complex, LALBA binding to B4GALT1 in the Golgi lumen alters the enzyme's acceptor specificity, enabling transfer of galactose to glucose rather than GlcNAc, thereby producing lactose (sadovnikova2021acomparativereview pages 1-3). Comparative reviews of lactose synthesis across mammalian species identify this B4GALT1-LALBA complex as the catalytic core of lactose biosynthesis, with expression and assembly regulated during lactation (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). This represents a tissue-specific, context-dependent complex rather than a universal feature of B4GALT1 function.

Interaction with Nucleotide Sugar Transporter: B4GALT1 interacts with the UDP-galactose transporter SLC35A2 in the Golgi membrane (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2). Using the NanoBiT assay, investigators demonstrated that SLC35A2 forms both homomers and heteromeric interactions with B4GALT1, and that these interactions are sensitive to intracellular UDP-Gal levels and the presence of cytosolic UDP-Gal biosynthetic enzymes (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2). This functional interaction suggests a coordinated organization of nucleotide sugar supply and glycosyltransferase activity within the Golgi membrane, though whether this constitutes a stable multiprotein complex or represents transient functional associations remains to be fully defined.

4. Biological Process Roles

4.1 Core Constitutive Functions

Protein N-Glycosylation and Galactosylation: The most robustly supported biological process role for B4GALT1 is its participation in protein N-glycosylation, specifically in the galactosylation step that generates complex N-glycan structures (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, tang2023transcriptomicandglycomic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). B4GALT1 transfers galactose from UDP-Gal to terminal GlcNAc residues on N-glycans, producing Galβ1-4GlcNAc (type 2 LacNAc) termini that serve as scaffolds for further glycan extension and lectin recognition (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). This function represents a core housekeeping activity of the enzyme across diverse cell types and tissues.

Reviews of nucleotide sugar delivery and Golgi glycosylation pathways consistently place B4GALT1 within the glycosyltransferase machinery responsible for stepwise N-glycan maturation in the Golgi apparatus (maszczakseneczko2022deliveryofnucleotide pages 1-2). Transcriptomic studies in Alzheimer's disease brain tissue linking B4GALT1 upregulation with increased galactosylated N-glycan abundance provide correlative support for this functional role at the tissue level (tang2023transcriptomicandglycomic pages 1-2).

Lactose Biosynthesis (Tissue-Specific): In lactating mammary gland, B4GALT1 executes a specialized biological process: lactose biosynthesis (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). As the catalytic component of the lactose synthase complex, B4GALT1 works in concert with LALBA to transfer galactose to glucose, producing lactose in the Golgi lumen for secretion into milk (sadovnikova2021acomparativereview pages 1-3). Comparative analyses across mammalian species confirm this tissue-restricted function, with B4GALT1 expression and complex formation regulated during pregnancy, lactation, and involution (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). This well-supported process should be annotated with clear tissue/developmental stage restrictions.

Biological process / candidate GO area B4GALT1 role Evidence in human / close system Evidence quality Core vs context-specific assessment Annotation risk assessment
Protein N-glycosylation B4GALT1 is a Golgi glycosyltransferase that transfers galactose from UDP-Gal to terminal GlcNAc on glycoprotein N-glycans, contributing to maturation of complex N-glycans and formation of type 2 LacNAc units (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, tang2023transcriptomicandglycomic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Reviews and mechanistic studies place B4GALT1 in the Golgi N-glycosylation machinery; AD brain transcriptomic/glycomic analysis linked increased B4GALT1 expression with increased corresponding N-glycans (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, tang2023transcriptomicandglycomic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Strong, direct for biochemical role; moderate for tissue-level glycome consequences (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, tang2023transcriptomicandglycomic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Core constitutive function Low risk; strongest GO-relevant process annotation
Protein glycan galactosylation / N-acetyllactosamine biosynthesis Produces Galβ1-4GlcNAc termini on glycoproteins, creating LacNAc scaffolds that can support further glycan extension and lectin interactions (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Platelet/megakaryocyte and AD-related studies associate B4GALT1 expression with increased LacNAc/galactosylated glycan abundance (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2) Strong for pathway placement; moderate for cell-type-specific outcomes (tang2023transcriptomicandglycomic pages 1-2, buduo2021increasedb4galt1expression pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Core constitutive function Low risk if framed as glycoprotein galactosylation rather than broad signaling
Lactose biosynthetic process In mammary epithelial cells, B4GALT1 forms lactose synthase with LALBA/alpha-lactalbumin and transfers galactose to glucose to produce lactose in the Golgi (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2) Comparative lactose synthesis reviews identify B4GALT1 as the catalytic component of lactose synthase and place the complex in the Golgi (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2) Strong for mammary/lactation context (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2) Well-supported tissue-specific function, not universal across all tissues Low risk if clearly restricted to lactating mammary gland context
Regulation of cell adhesion via integrin glycosylation B4GALT1 modifies N-glycans on integrin α6 and β1, altering laminin adhesion properties of HCC cells (chen2023decreasedb4galt1promotes pages 1-2) In HCC cells, mass spectrometry and lectin pull-down identified integrin α6/β1 as B4GALT1 substrates; B4GALT1 loss increased laminin adhesion and promoted invasion (chen2023decreasedb4galt1promotes pages 1-2) Strong direct evidence in a cancer-cell context (chen2023decreasedb4galt1promotes pages 1-2) Context-specific downstream consequence of core glycosylation activity Moderate risk; should not be generalized as a constitutive organism-wide adhesion regulator without context
Positive/negative regulation of cancer cell migration and invasion Altered B4GALT1 expression changes migration/invasion phenotypes in multiple cancer models, likely through glycosylation of receptors/integrins and microenvironmental interactions (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2) HCC: B4GALT1 loss promoted migration/invasion and metastasis; CRC: B4GALT1 depletion reduced metastatic potential in a galectin-8/TGFBR2 context; inhibitor study reduced migration/invasion in carcinoma cells but is pharmacologic and family-level in interpretation (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2) Strong direct evidence for specific tumor models, but direction of effect is context-dependent (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2) Pleiotropic disease-context role, not core housekeeping process High risk for generic GO process annotation because effects vary by tissue, receptor context, and disease state
Modulation of TGF-β receptor signaling / EMT suppression in CRC B4GALT1-dependent galactosylation supports galectin-8 binding to TβRII, which dampens non-canonical TGF-β signaling and suppresses EMT/metastasis in CRC cells (hsu2024b4galt1dependentgalectin8binding pages 1-2) CRC study showed galectin-8 anti-migratory effects depend on B4GALT1; depletion of B4GALT1 reduced metastatic potential and altered signaling output (hsu2024b4galt1dependentgalectin8binding pages 1-2) Strong direct evidence in one cancer system (hsu2024b4galt1dependentgalectin8binding pages 1-2) Context-specific signaling consequence secondary to glycosylation High risk if converted into broad annotations such as “TGF-β signaling regulator” without disease/tissue restriction
Platelet/megakaryocyte glycosylation and thrombopoietin-associated regulation Increased B4GALT1 expression in MPN megakaryocytes associated with increased platelet surface LacNAc and elevated plasma TPO levels (buduo2021increasedb4galt1expression pages 1-2) Human MPN study found correlation between megakaryocyte B4GALT1 expression and platelet galactosylation/TPO axis (buduo2021increasedb4galt1expression pages 1-2) Moderate; disease-linked human association with mechanistic interpretation, but not a full causal gene knockout/rescue framework in human cells (buduo2021increasedb4galt1expression pages 1-2) Context-specific hematologic/disease role built on core glycosylation activity Moderate to high risk for direct GO process transfer; better treated as phenotype association than core biological process
Apoptotic process regulation B4GALT1 perturbation influences apoptosis markers and cell death phenotypes in glioblastoma and CRC systems; inhibitor studies also trigger apoptosis in carcinoma cells (hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) Glioblastoma knockdown increased apoptosis and autophagy; CRC study found recombinant galectin-8 induces JNK-dependent apoptosis in a B4GALT1-dependent glycosylation context; inhibitor 612 activated apoptotic pathways in HCC cells (hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) Moderate for cell-line phenotypes, weak for assigning a direct physiological apoptosis role to B4GALT1 itself (dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) Pleiotropic, model-dependent consequence High risk; likely over-extended if annotated as direct apoptosis regulator in GO
Autophagy regulation Knockdown in glioblastoma altered autophagy markers along with tumor phenotypes (wang2020b4galt1regulatesapoptosis pages 1-2) Single disease-model paper reported increased Beclin-1/LC3-associated autophagy upon B4GALT1 knockdown (wang2020b4galt1regulatesapoptosis pages 1-2) Limited, model-specific (wang2020b4galt1regulatesapoptosis pages 1-2) Context-specific, indirect Very high risk; not suitable as core annotation without broader corroboration
Inflammatory signaling Current evidence is mostly indirect: glycan remodeling by B4GALT1 can influence lectin/receptor interactions and immune-associated phenotypes, but no strong direct evidence in the reviewed set supports B4GALT1 as a primary inflammatory signaling mediator in human cells (hsu2024b4galt1dependentgalectin8binding pages 1-2, buduo2021increasedb4galt1expression pages 1-2) CRC and hematologic studies imply immune/lectin-linked consequences of B4GALT1-dependent glycans, but do not establish a canonical inflammatory signaling function for B4GALT1 itself (hsu2024b4galt1dependentgalectin8binding pages 1-2, buduo2021increasedb4galt1expression pages 1-2) Weak to moderate, mostly inferential (hsu2024b4galt1dependentgalectin8binding pages 1-2, buduo2021increasedb4galt1expression pages 1-2) Pleiotropic and indirect High risk; avoid broad inflammatory signaling annotations
Neuronal / synaptic / developmental cell death roles No strong direct evidence in the reviewed set supports a specific neuronal, synaptic remodeling, pyroptotic, or developmental cell-death function for human B4GALT1; AD study links expression changes to glycomic alterations, not direct neuronal mechanism (tang2023transcriptomicandglycomic pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) AD transcriptomic/glycomic study is correlative for brain glycosylation changes; glioblastoma apoptosis paper is cancer-specific and not evidence of normal neuronal biology (tang2023transcriptomicandglycomic pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) Weak for these specialized roles (tang2023transcriptomicandglycomic pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2) Not supported as core biology from current evidence set Very high risk; should not be annotated based on current evidence
Protein processing / Golgi enzyme secretion B4GALT1 can undergo proteolytic shedding as part of Golgi-enzyme turnover/secretion pathways, but this reflects protein processing/localization control more than a primary biological process executed by B4GALT1 (hobohm2022nterminomeanalysesunderscore pages 1-2) SPPL3-centered study supports secretion of Golgi enzymes via intramembrane proteolysis and includes B4GALT1 in the broader secretion context (hobohm2022nterminomeanalysesunderscore pages 1-2) Moderate for processing/localization biology (hobohm2022nterminomeanalysesunderscore pages 1-2) Relevant to maturation/localization state, not core downstream organismal function Moderate risk if misinterpreted as secreted enzyme being the dominant physiological state
Cytoplasm/cytosol/nucleus/signaling-complex annotations The reviewed literature supports Golgi-resident type II membrane topology with luminal catalytic domain, not functional localization in cytosol, nucleus, or canonical cytosolic signaling complexes (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Localization studies and reviews consistently place B4GALT1 in the Golgi/trans-Golgi glycosylation machinery (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Strong negative evidence against these alternative active-site localizations (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, yagi2024decipheringthesubgolgi pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2) Not a biological process role, but critical for annotation boundaries Low risk to exclude; high risk only if over-annotated to cytosol/nucleus/signaling complexes

Table: This table distinguishes B4GALT1’s core GO-relevant biological processes from tissue-specific and disease-context roles, and flags where annotation transfer would be low-risk versus potentially over-extended. It is useful for prioritizing constitutive glycosylation functions over pleiotropic cancer or cell-death phenotypes.

4.2 Context-Specific and Pleiotropic Roles

Cancer Cell Migration and Invasion: Multiple cancer-focused studies report that altered B4GALT1 expression modulates cell migration and invasion phenotypes, but the direction and mechanism vary by tumor type and cellular context (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2). In hepatocellular carcinoma, B4GALT1 downregulation was associated with increased invasiveness; knockdown or knockout enhanced HCC cell migration and invasion in vitro and promoted lung metastasis in NOD/SCID mice (chen2023decreasedb4galt1promotes pages 1-2). Mechanistically, B4GALT1 loss altered N-glycosylation of integrin α6 and β1, increasing laminin adhesion and activating integrin-FAK signaling (chen2023decreasedb4galt1promotes pages 1-2).

Conversely, in colorectal cancer, B4GALT1 depletion reduced metastatic potential in an intra-splenic injection model, with the anti-migratory effect mediated through B4GALT1-dependent galactosylation enabling galectin-8 binding to TGF-β receptor (hsu2024b4galt1dependentgalectin8binding pages 1-2). Similarly, retinoblastoma studies found B4GALT3 (a related family member) promoted invasion through β1-integrin glycosylation and FAK activation, suggesting family-level glycosylation effects on integrin signaling (tang2026β14galactosyltransferaseiiidrives pages 1-4).

These findings indicate that B4GALT1's effects on migration and invasion are pleiotropic consequences of glycosylation changes that alter receptor-ligand interactions and signaling networks in disease contexts, rather than evidence of a dedicated role in regulating cell motility as a constitutive biological process. The tumor-type-specific and context-dependent nature of these effects argues against generic GO annotations for migration/invasion regulation.

Apoptosis and Cell Death: Several studies report associations between B4GALT1 perturbation and altered apoptosis markers, but the evidence is limited and context-specific (hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2). In glioblastoma cell lines, B4GALT1 knockdown by lentivirus increased apoptosis markers including cleaved caspase-3, Bax upregulation, and Bcl-2 downregulation, while also increasing autophagy markers Beclin-1 and LC3 (wang2020b4galt1regulatesapoptosis pages 1-2). A β4GalT1 inhibitor (compound 612) induced ER stress, Golgi stress, G2/M cell cycle arrest, and activated apoptotic pathways in hepatocellular carcinoma cells (dai2026cytotoxiceffectof pages 1-2). In colorectal cancer, recombinant galectin-8 treatment induced JNK-dependent apoptosis in a B4GALT1-glycosylation-dependent context (hsu2024b4galt1dependentgalectin8binding pages 1-2).

While these observations link B4GALT1 to cell death phenotypes in specific disease models, they do not establish a direct, constitutive role for B4GALT1 in apoptosis regulation across normal human tissues. The effects appear to reflect downstream consequences of perturbing glycosylation networks and cellular homeostasis rather than indicating that apoptosis regulation is a primary biological process executed by B4GALT1. Annotation of B4GALT1 as a direct apoptosis regulator would likely represent an over-extension of disease-model findings.

Inflammatory and Signaling Roles: Current evidence for B4GALT1 in inflammatory signaling or canonical signaling pathways is largely indirect (hsu2024b4galt1dependentgalectin8binding pages 1-2, buduo2021increasedb4galt1expression pages 1-2). Glycan remodeling by B4GALT1 influences lectin-glycan and receptor-glycan interactions that can have immune-associated consequences, but no strong direct evidence supports B4GALT1 as a primary inflammatory mediator in the reviewed literature. The platelet/megakaryocyte study linking B4GALT1 expression to thrombopoietin levels in myeloproliferative neoplasms represents a disease-associated correlation rather than a demonstrated constitutive signaling function (buduo2021increasedb4galt1expression pages 1-2).

4.3 Annotation Risk Assessment

The reviewed evidence supports the following annotation priority framework:

Low Risk (Core Annotations):
- Protein N-glycosylation / N-glycan galactosylation
- UDP-galactose:N-acetylglucosamine β-1,4-galactosyltransferase activity
- Golgi apparatus / trans-Golgi localization
- Lactose biosynthetic process (with tissue restriction to mammary gland)

Moderate Risk (Context-Dependent):
- Regulation of cell adhesion (limited to specific integrin-glycosylation contexts)
- Protein processing/Golgi enzyme secretion (applies to processed form, not dominant state)
- Platelet-related glycosylation (disease-associated, requires careful framing)

High Risk (Pleiotropic/Over-Extended):
- Generic cell migration/invasion regulation annotations
- Direct apoptosis or autophagy regulation
- Inflammatory signaling pathway membership
- Developmental cell death or neuronal-specific roles
- TGF-β signaling pathway regulation (context-specific in CRC)

Very High Risk (Unsupported):
- Pyroptosis, synaptic remodeling, or other specialized cell death pathways
- Nuclear localization or nuclear complex membership
- Cytosolic signaling complex membership (conflicts with type II membrane topology)

5. Protein Structure and Isoforms

B4GALT1 is consistently described as a type II transmembrane protein, with structural features including an N-terminal cytoplasmic tail, a single transmembrane domain, a stem region, and a C-terminal luminal catalytic domain (hobohm2022nterminomeanalysesunderscore pages 1-2, chatterjee2023centralroleof pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2). Studies of B4GALT4 N-glycosylation demonstrated that glycosylation sites within the catalytic domain are crucial for enzymatic activity and Golgi localization, suggesting this may apply to other family members including B4GALT1 (maszczakseneczko2022deliveryofnucleotide pages 1-2).

The secreted form arises through proteolytic processing rather than representing a distinct alternative isoform with fundamentally different catalytic properties (hobohm2022nterminomeanalysesunderscore pages 1-2). Both full-length membrane-anchored and processed soluble forms retain galactosyltransferase activity, with the secreted form described in UniProt as proficient in activity and potentially involved in extracellular glycan remodeling.

6. Key Literature Summary

Recent Highly Relevant Papers (2023-2025):

Molecular Function & Substrates:
- Wiertelak et al. (2025) demonstrated that B4GALT1 interacts with UDP-Gal transporter SLC35A2, with interactions sensitive to nucleotide sugar availability (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2)
- Chen et al. (2023) identified integrin α6 and β1 as major B4GALT1 substrates in HCC via mass spectrometry, linking B4GALT1 to laminin-integrin pathway regulation (chen2023decreasedb4galt1promotes pages 1-2)
- Xu & Mou (2025) reported first selective small-molecule B4GALT1 inhibitor (compound 1105486) targeting UDP-galactose pocket for pancreatic cancer (xu2025discoveryofcompound pages 1-2)

Localization & Complexes:
- Yagi et al. (2024) used B4GALT1 as trans-Golgi marker in 3D super-resolution imaging, demonstrating CTS region determines sub-Golgi positioning (yagi2024decipheringthesubgolgi pages 1-2)
- Slater et al. (2025) reviewed B4GALT1 role in lactose synthase complex and HMO biosynthesis pathways in mammary gland (slater2025glycosyltransferasesglycoengineersin pages 1-2)

Biological Processes:
- Tang et al. (2023) linked B4GALT1 upregulation in Alzheimer's disease brain to increased galactosylated N-glycans via transcriptomic/glycomic analysis (tang2023transcriptomicandglycomic pages 1-2)
- Hsu et al. (2024) showed B4GALT1-dependent galectin-8 binding to TGF-β receptor suppresses CRC metastasis (hsu2024b4galt1dependentgalectin8binding pages 1-2)
- Dai et al. (2026) demonstrated β4GalT1 inhibitor induces ER/Golgi stress and apoptosis in hepatocellular carcinoma (dai2026cytotoxiceffectof pages 1-2)

Protein Processing:
- Hobohm et al. (2022) identified SPPL3-mediated intramembrane proteolysis as mechanism for B4GALT1 secretion via N-terminomics (hobohm2022nterminomeanalysesunderscore pages 1-2)

Foundational References:

  • Sadovnikova et al. (2021) provided comprehensive review of lactose synthesis biochemistry and B4GALT1-LALBA lactose synthase complex (sadovnikova2021acomparativereview pages 1-3)
  • Maszczak-Seneczko et al. (2022) reviewed nucleotide sugar delivery to Golgi and glycosyltransferase organization (maszczakseneczko2022deliveryofnucleotide pages 1-2)
  • Chatterjee et al. (2023, 2025) discussed β1,4-GalT family roles in cancer, inflammation, and disease-centric pathways (chatterjee2023centralroleof pages 1-2)

7. Conclusions and Recommendations

B4GALT1 functions primarily as a trans-Golgi-localized type II transmembrane glycosyltransferase that catalyzes β1,4-galactosylation of terminal GlcNAc residues on glycoprotein N-glycans, using UDP-galactose as sugar donor. This represents the core, constitutive molecular function and biological process role supported by the strongest experimental evidence (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2, tang2023transcriptomicandglycomic pages 1-2, maszczakseneczko2022deliveryofnucleotide pages 1-2).

In lactating mammary epithelium, B4GALT1 forms a well-characterized tissue-specific complex with alpha-lactalbumin to execute lactose biosynthesis, a specialized function distinct from its general glycosylation role (sadovnikova2021acomparativereview pages 1-3, slater2025glycosyltransferasesglycoengineersin pages 1-2). The enzyme can undergo SPPL3-mediated proteolytic processing to generate a secreted form, though the physiological significance of secreted B4GALT1 activity remains less well-defined than its Golgi-resident function (hobohm2022nterminomeanalysesunderscore pages 1-2).

Context-specific roles in cancer cell migration, apoptosis, and signaling pathways reflect pleiotropic downstream consequences of altered glycosylation in disease states rather than core biological processes (chen2023decreasedb4galt1promotes pages 1-2, hsu2024b4galt1dependentgalectin8binding pages 1-2, dai2026cytotoxiceffectof pages 1-2, wang2020b4galt1regulatesapoptosis pages 1-2). These should be annotated with caution and appropriate context restrictions to avoid over-extending findings from disease models to general biological function.

For GO annotation purposes, priority should be given to protein N-glycosylation/galactosylation, Golgi/trans-Golgi localization, lactose synthase complex (with tissue restriction), and galactosyltransferase activity. Annotations related to apoptosis, migration, inflammation, or specialized signaling pathways carry higher risk of over-interpretation and should be approached conservatively or avoided unless additional supporting evidence emerges from normal physiological contexts.

References

  1. (wiertelak2025cytosolicudpgalbiosynthetic pages 1-2): Wojciech Wiertelak, Artem Pavlovskyi, Mariusz Olczak, and Dorota Maszczak-Seneczko. Cytosolic udp-gal biosynthetic machinery is required for dimerization of slc35a2 in the golgi membrane and its interaction with b4galt1. Frontiers in Molecular Biosciences, Mar 2025. URL: https://doi.org/10.3389/fmolb.2025.1563384, doi:10.3389/fmolb.2025.1563384. This article has 4 citations.

  2. (maszczakseneczko2022deliveryofnucleotide pages 1-2): Dorota Maszczak-Seneczko, Maciej Wiktor, Edyta Skurska, Wojciech Wiertelak, and Mariusz Olczak. Delivery of nucleotide sugars to the mammalian golgi: a very well (un)explained story. International Journal of Molecular Sciences, 23:8648, Aug 2022. URL: https://doi.org/10.3390/ijms23158648, doi:10.3390/ijms23158648. This article has 27 citations.

  3. (yagi2024decipheringthesubgolgi pages 1-2): Hirokazu Yagi, Seigo Tateo, Taiki Saito, Yusaku Ohta, Emiko Nishi, Saemi Obitsu, Tatsuya Suzuki, Supaphorn Seetaha, Charles Hellec, Akihiko Nakano, Takuro Tojima, and Koichi Kato. Deciphering the sub-golgi localization of glycosyltransferases via 3d super-resolution imaging. Cell Structure and Function, 49:47-55, Jul 2024. URL: https://doi.org/10.1247/csf.24008, doi:10.1247/csf.24008. This article has 15 citations and is from a peer-reviewed journal.

  4. (sadovnikova2021acomparativereview pages 1-3): Anna Sadovnikova, Sergio C. Garcia, and Russell C. Hovey. A comparative review of the cell biology, biochemistry, and genetics of lactose synthesis. Journal of Mammary Gland Biology and Neoplasia, 26:181-196, Jun 2021. URL: https://doi.org/10.1007/s10911-021-09490-7, doi:10.1007/s10911-021-09490-7. This article has 67 citations and is from a peer-reviewed journal.

  5. (slater2025glycosyltransferasesglycoengineersin pages 1-2): Alanna S. Slater, Andrew G. McDonald, Rita M. Hickey, and Gavin P. Davey. Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. Frontiers in Molecular Biosciences, Apr 2025. URL: https://doi.org/10.3389/fmolb.2025.1587602, doi:10.3389/fmolb.2025.1587602. This article has 8 citations.

  6. (chen2023decreasedb4galt1promotes pages 1-2): Po-Da Chen, Ying-Yu Liao, Yu-Chia Cheng, Hsin-Yi Wu, Yao-Ming Wu, and Min-Chuan Huang. Decreased b4galt1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway. Oncogenesis, Oct 2023. URL: https://doi.org/10.1038/s41389-023-00494-y, doi:10.1038/s41389-023-00494-y. This article has 19 citations and is from a domain leading peer-reviewed journal.

  7. (hsu2024b4galt1dependentgalectin8binding pages 1-2): Tzu-Hui Hsu, Yu-Chan Chang, Yi-Yuan Lee, Chi-Long Chen, Michael Hsiao, Fan-Ru Lin, Li-Han Chen, Chun-Hung Lin, Takashi Angata, Fu-Tong Liu, and Kuo-I Lin. B4galt1-dependent galectin-8 binding with tgf-β receptor suppresses colorectal cancer progression and metastasis. Cell Death & Disease, Sep 2024. URL: https://doi.org/10.1038/s41419-024-07028-3, doi:10.1038/s41419-024-07028-3. This article has 11 citations and is from a peer-reviewed journal.

  8. (dai2026cytotoxiceffectof pages 1-2): Zhe Dai, Ming Sun, Lihang Chen, Xueqi Fu, Wenfu Yan, Yin Gao, and Inka Brockhausen. Cytotoxic effect of a β1,4-galactosyltransferase inhibitor in hepatic carcinoma cells. Cells, 15:251, Jan 2026. URL: https://doi.org/10.3390/cells15030251, doi:10.3390/cells15030251. This article has 0 citations.

  9. (wang2020b4galt1regulatesapoptosis pages 1-2): Pu Wang, Xiaolong Li, and Yuan Xie. B4galt1 regulates apoptosis and autophagy of glioblastoma in vitro and in vivo. Technology in Cancer Research & Treatment, Dec 2020. URL: https://doi.org/10.1177/1533033820980104, doi:10.1177/1533033820980104. This article has 21 citations and is from a peer-reviewed journal.

  10. (chatterjee2023centralroleof pages 1-2): Subroto Chatterjee, Rebecca Yuan, Spriha Thapa, and Resham Talwar. Central role of β-1,4-galt-v in cancer signaling, inflammation, and other disease-centric pathways. International Journal of Molecular Sciences, 25:483, Dec 2023. URL: https://doi.org/10.3390/ijms25010483, doi:10.3390/ijms25010483. This article has 5 citations.

  11. (xu2025discoveryofcompound pages 1-2): Yunyun Xu and Yiping Mou. Discovery of compound 1105486 as a selective inhibitor of b4galt1: potential for pancreatic cancer therapy. Frontiers in Chemistry, Aug 2025. URL: https://doi.org/10.3389/fchem.2025.1651402, doi:10.3389/fchem.2025.1651402. This article has 0 citations.

  12. (tang2023transcriptomicandglycomic pages 1-2): Xinyu Tang, Jennyfer Tena, Jacopo Di Lucente, Izumi Maezawa, Danielle J. Harvey, Lee-Way Jin, Carlito B. Lebrilla, and Angela M. Zivkovic. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to alzheimer’s disease. Scientific Reports, May 2023. URL: https://doi.org/10.1038/s41598-023-34787-4, doi:10.1038/s41598-023-34787-4. This article has 45 citations and is from a peer-reviewed journal.

  13. (buduo2021increasedb4galt1expression pages 1-2): Christian A. Di Buduo, Silvia Giannini, Vittorio Abbonante, Vittorio Rosti, Karin M. Hoffmeister, and Alessandra Balduini. Increased b4galt1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in mpns. Blood, 137(15):2085-2089, Apr 2021. URL: https://doi.org/10.1182/blood.2020007265, doi:10.1182/blood.2020007265. This article has 21 citations and is from a highest quality peer-reviewed journal.

  14. (hobohm2022nterminomeanalysesunderscore pages 1-2): Laura Hobohm, Tomas Koudelka, Fenja H. Bahr, Jule Truberg, Sebastian Kapell, Sarah-Sophie Schacht, Daniel Meisinger, Marion Mengel, Alexander Jochimsen, Anna Hofmann, Lukas Heintz, Andreas Tholey, and Matthias Voss. N-terminome analyses underscore the prevalence of sppl3-mediated intramembrane proteolysis among golgi-resident enzymes and its role in golgi enzyme secretion. Cellular and Molecular Life Sciences: CMLS, Mar 2022. URL: https://doi.org/10.1007/s00018-022-04163-y, doi:10.1007/s00018-022-04163-y. This article has 21 citations.

  15. (tang2026β14galactosyltransferaseiiidrives pages 1-4): Junjie Tang, Jinmiao Li, Meng Wang, Yaoming Liu, Hetian Sun, Zhihui Zhang, Yang Gao, Chao Cheng, Shuxia Chen, Ping Zhang, Siming Ai, Shicai Su, Youjin Hu, and Rong Lu. Β1,4-galactosyltransferase iii drives retinoblastoma invasion via activation of integrin-fak axis. Cell Death & Disease, Mar 2026. URL: https://doi.org/10.1038/s41419-026-08620-5, doi:10.1038/s41419-026-08620-5. This article has 0 citations and is from a peer-reviewed journal.

📚 Additional Documentation

Notes

(B4GALT1-notes.md)

B4GALT1 (human, UniProt P15291) — gene review notes

Identity and overview

  • HGNC: B4GALT1 (synonym GGTB2). UniProt P15291 (B4GT1_HUMAN), 398 aa.
  • Beta-1,4-galactosyltransferase 1 (beta4Gal-T1 / B4GalT1). CAZy family GT7.
  • Type II single-pass Golgi membrane glycosyltransferase: short N-terminal cytosolic
    tail, single transmembrane domain, stem region, C-terminal luminal catalytic domain.
  • Multiple EC numbers reflect distinct acceptors of the SAME catalytic chemistry
    (transfer of Gal from UDP-Gal in beta-1,4 linkage): EC 2.4.1.38 (to GlcNAc on
    glycoproteins/N-glycans), EC 2.4.1.90 (to free GlcNAc -> LacNAc), EC 2.4.1.22
    (lactose synthase, to glucose, only with alpha-lactalbumin), EC 2.4.1.275 (to GlcNAc
    on glycolipids).

Core molecular function (verified from primary literature)

  • Transfers galactose from UDP-alpha-D-galactose in beta(1->4) linkage to non-reducing
    terminal GlcNAc of complex N-glycans and glycolipids, forming Galbeta1-4GlcNAc
    (type-2 N-acetyllactosamine, LacNAc). [UniProt P15291 FUNCTION; PMID:16157350 "beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked oligosaccharide chains of glycoproteins"]
  • Branch specificity: prefers the 1,2-1,6-arm GlcNAc of biantennary N-glycans
    (~10-fold lower Km than the 1,3-arm). PMID:16157350
  • Mn2+ is a required cofactor (crystallized with Mn2+ and GlcNAc/UDP). [UniProt CC COFACTOR; PMID:16157350]
  • Catalytic/substrate-binding residues mapped by mutagenesis: Tyr284, Tyr309, Trp310
    critical for GlcNAc binding; Tyr309 also in UDP-Gal binding. PMID:2120039
  • Galactosylates IgG Fc N-glycans (Asn297), a prerequisite for downstream sialylation;
    used widely as a glyco-engineering tool. [PMID:27872474; PMID:29133956; PMID:37632720; PMID:38321209 — all EXP/IDA for beta-1,4-GalT activity in GOA]

Lactose synthase (bifunctional, mammary-specific)

  • With LALBA/alpha-lactalbumin forms the lactose synthase complex (1:1). alpha-LA
    promotes glucose binding to beta4Gal-T1, switching acceptor specificity from GlcNAc
    to glucose so the complex makes lactose (Galbeta1-4Glc). PMID:11419947
  • Conformational change (residues ~345-365, His347 metal coordination, hydrophobic
    N-acetyl pocket Arg359/Phe360/Ile363) underlies the acceptor switch. PMID:11419947
  • This is a CORE, evolutionarily selected function in lactating mammary gland — not a
    pleiotropic side effect. Both LacNAc synthesis and lactose synthesis are core.

Localization

  • Resident enzyme of the trans-Golgi cisternae (codistributes with TPPase in trans
    Golgi). PMID:6121819
  • Golgi retention via the transmembrane domain; homodimerizes (Cys29/His32 dependent)
    and associates with alpha/beta-tubulin. PMID:7744867
  • HPA IDA + Ensembl/Reactome all place it in Golgi/Golgi membrane. CORE location = Golgi
    apparatus / Golgi membrane / Golgi trans cisterna.

Cell-surface / secreted pools (context-specific, NON-CORE)

  • A long isoform with a 13-aa N-terminal cytoplasmic extension (alternative initiation)
    is preferentially targeted to the plasma membrane; the short isoform is the Golgi
    form. PMID:1714903
  • Cell-surface GalT proposed as a cell-cell/cell-matrix recognition molecule and ZP3
    sperm receptor; this is the LONG isoform (P15291-1) and is a secondary/specialized
    role (UniProt FUNCTION [Isoform Long], By similarity to mouse P15535). Treat as
    non-core.
  • ecto-GalT on enterocyte brush border / basolateral membrane / desmosome / external
    side of PM. PMID:3917437 — surface pool, non-core; "desmosome" is incidental immuno-EM localization.
  • Soluble/secreted GalT in milk, amniotic fluid, ascites (proteolytic shedding of the
    catalytic domain) retains activity. PMID:33805 Explains extracellular-region/exosome CC annotations. The processed secreted form is catalytically active (UniProt) but the dominant physiological state is Golgi-resident — secreted/exosome locations are non-core.

Disease

  • Hypomorphic/LoF mutations cause CDG type IId (CDG2D), a congenital disorder of
    glycosylation. [UniProt: PMID:11901181, PMID:30653653, PMID:32157688 (CDG2D variants);
    not in GOA annotation set]
  • Amish missense p.Asn352Ser reduces GalT activity ~50%, lowers LDL-C and fibrinogen,
    reduces coronary artery disease risk, via reduced galactosylation/sialylation of
    ApoB100, fibrinogen, IgG, transferrin. PMID:34855475 This is the basis for the IMP "positive regulation of circulating fibrinogen levels" and "lipid metabolic process" annotations — these are downstream physiological/disease consequences of the core galactosyltransferase activity, NOT direct dedicated B4GALT1 processes. Treat as non-core / over-annotation.

Annotation strategy summary

  • CORE MF: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
    (GO:0003831); N-acetyllactosamine synthase activity (GO:0003945); lactose synthase
    activity (GO:0004461); manganese ion binding (GO:0030145).
  • CORE BP: protein N-linked glycosylation (GO:0006487); lactose biosynthetic process
    (GO:0005989).
  • CORE CC: Golgi membrane (GO:0000139) / Golgi apparatus (GO:0005794) / Golgi trans
    cisterna (GO:0000138).
  • Generic MF terms (galactosyltransferase activity GO:0008378, glycosyltransferase
    activity GO:0016757, UDP-galactosyltransferase activity GO:0035250) -> MODIFY to the
    specific beta-1,4-GalT activity.
  • Generic/parent processes (carbohydrate metabolic GO:0005975, oligosaccharide
    biosynthetic GO:0009312) -> MODIFY/over-annotated.
  • protein-containing complex (GO:0032991) -> too generic; the real complex is lactose
    synthase. MODIFY toward a complex term or mark over-annotated; there is no
    lactose-synthase complex GO CC term -> propose one.
  • Surface/secreted/exosome/granule/desmosome/filopodium CC -> KEEP_AS_NON_CORE or
    over-annotated (surface long-isoform pool + shed soluble form, not the core Golgi
    function).
  • IMP fibrinogen/lipid BP -> downstream disease physiology, non-core.

Falcon integration (dated 2026-06-21)

The provided report is B4GALT1-deep-research-falcon.md (an LLM deep-research synthesis
with non-resolvable internal citation keys, e.g. "wiertelak2025...", "chen2023..."; these
are NOT fetchable PMIDs, so per workflow they are used for orientation only and NOT cited
as supporting_text in the YAML).

Findings USED (concordant with primary literature / UniProt, and independently verified
here):
- Core MF = beta-1,4-GalT transferring Gal from UDP-Gal to terminal GlcNAc, forming
type-2 LacNAc; Mn2+ cofactor; UDP-Gal donor. (Matches UniProt + PMID:16157350.)
- Core localization = trans-Golgi / Golgi membrane, type II topology. (Matches
PMID:6121819, PMID:7744867.)
- Lactose synthase with LALBA is a well-supported, tissue-specific core function.
(Matches PMID:11419947.)
- Downstream cancer migration/invasion, apoptosis, autophagy, inflammatory and
TGF-beta/galectin-8 roles are pleiotropic, context-specific consequences of altered
glycosylation, NOT core B4GALT1 processes, and should not be annotated as dedicated
processes. (Concordant with the "do not over-annotate pleiotropic BP" guidance; none
of these are in the GOA set anyway.)
- The report's framing that cytosol/nucleus localization is unsupported is correct.

Findings REJECTED or DOWNWEIGHTED (and why):
- All specific cancer/disease mechanistic claims (chen2023 integrin alpha6/beta1
substrates in HCC; hsu2024 galectin-8/TGFBR2 in CRC; dai2026 inhibitor apoptosis;
wang2020 glioblastoma apoptosis/autophagy; buduo2021 platelet TPO; tang2023 Alzheimer
glycomics; xu2025 inhibitor Arg187/Glu313) rest on non-resolvable citation keys that I
could not verify against fetchable PMIDs. They are plausible but unverifiable here, are
not in the GOA annotation set, and do not change any annotation action. NOT used as
evidence; recorded here only as context.
- The report repeatedly conflates B4GALT1 with family members (e.g. B4GALT3 in
retinoblastoma) and uses "B4GALT family" effects; I did not transfer any family-level
claim to B4GALT1.
- The active-site residue numbers quoted by Falcon (Arg187/Glu313) differ from the
experimentally verified substrate-binding residues in PMID:2120039 (Tyr284/Tyr309/
Trp310) and PMID:11419947 (His347, Arg359/Phe360/Ile363); I used only the primary,
verified residues and ignored the Falcon residue numbers.

📄 View Raw YAML

 
id: P15291
gene_symbol: B4GALT1
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  B4GALT1 encodes beta-1,4-galactosyltransferase 1 (beta4Gal-T1; CAZy family GT7),
  a type II single-pass membrane glycosyltransferase resident in the trans-Golgi
  cisternae. Its luminal catalytic domain transfers galactose from UDP-alpha-D-galactose
  in a beta-1,4 linkage onto the non-reducing terminal N-acetylglucosamine (GlcNAc) of
  complex-type N-glycans, of O-glycans, and of glycolipids, forming the
  Galbeta1-4GlcNAc (type-2 N-acetyllactosamine, LacNAc) unit that is the scaffold for
  further glycan extension (sialylation, fucosylation, poly-LacNAc). It requires Mn2+
  as cofactor. The same catalytic activity, applied to several distinct acceptors,
  underlies its multiple EC assignments (EC 2.4.1.38 on GlcNAc of glycoproteins;
  EC 2.4.1.90 on free GlcNAc to make LacNAc; EC 2.4.1.275 on glycolipids). The enzyme
  is uniquely bifunctional: in the lactating mammary gland it forms a 1:1 complex with
  alpha-lactalbumin (LALBA) called lactose synthase, in which alpha-lactalbumin lowers
  the Km for glucose and switches the acceptor specificity from GlcNAc to glucose, so
  the complex synthesizes lactose (Galbeta1-4Glc; EC 2.4.1.22), the major milk sugar.
  A distinct longer isoform bearing a 13-residue N-terminal cytoplasmic extension is
  preferentially delivered to the cell surface, where galactosyltransferase has been
  proposed to act as a cell-cell and cell-matrix recognition molecule (including as a
  sperm receptor for ZP3); a proteolytically processed soluble form is found in milk,
  amniotic fluid and serum. The dominant physiological state, however, is the
  Golgi-resident enzyme. Loss-of-function and hypomorphic variants cause congenital
  disorder of glycosylation type IId (CDG2D), and a hypomorphic missense allele
  (p.Asn352Ser) lowers serum LDL-cholesterol and fibrinogen by reducing their
  N-glycan galactosylation.
alternative_products:
- name: Long (Cell surface)
  id: P15291-1
  description: >-
    Isoform with a 13-residue N-terminal cytoplasmic extension generated by alternative
    initiation. Preferentially targeted to the plasma membrane, where it constitutes the
    cell-surface (ecto-) galactosyltransferase pool implicated in cell-cell/cell-matrix
    recognition and (by similarity to mouse) sperm ZP3 binding. This surface recognition
    role is specialized/non-core relative to the Golgi catalytic function.
- name: Short (Golgi complex)
  id: P15291-2
  sequence_note: VSP_018802
  description: >-
    Shorter isoform lacking the N-terminal extension; the canonical Golgi-resident form
    that carries out bulk N-glycan and glycolipid galactosylation and lactose synthesis.
existing_annotations:
# 1
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetically inferred Golgi residence for the GT7 family. This is the correct
      core compartment: B4GALT1 is a trans-Golgi resident type II membrane enzyme
      (codistributes with thiamine pyrophosphatase in trans-Golgi cisternae,
      PMID:6121819; IDA Golgi PMID:7744867). is_active_in is appropriate. Accept as a
      core location (the more granular Golgi membrane / Golgi trans cisterna terms are
      also present and preferred for specificity).
    action: ACCEPT
# 2
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetically inferred core catalytic activity, concordant with extensive direct
      experimental evidence (PMID:16157350 crystal structures + kinetics; multiple EXP/IDA
      annotations). This is the central, evolutionarily conserved molecular function of
      B4GALT1. Accept as core.
    action: ACCEPT
# 3
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Core biological process: B4GALT1 performs the galactosylation step of complex
      N-glycan maturation, adding Gal to terminal GlcNAc of N-glycan antennae (directly
      assayed in PMID:16157350; IgG Fc N-glycan galactosylation PMID:27872474). Accept as
      a core process.
    action: ACCEPT
# 4
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: located_in
  review:
    summary: >-
      Electronic (ARBA) Golgi membrane location, consistent with the experimentally
      established trans-Golgi membrane residence of this type II membrane enzyme. Correct
      and specific; accept as core location.
    action: ACCEPT
# 5
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic assignment (RHEA:22932 / EC 2.4.1.38) of the core catalytic activity,
      redundant with the experimentally supported IBA/IDA/EXP annotations to the same
      term. Correct; accept.
    action: ACCEPT
# 6
- term:
    id: GO:0003945
    label: N-acetyllactosamine synthase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic assignment (RHEA:17745 / EC 2.4.1.90) of the activity transferring Gal to
      free GlcNAc to make LacNAc. Experimentally supported (IDA PMID:16157350, PMID:33805,
      PMID:2120039) and a genuine facet of the core activity. Accept.
    action: ACCEPT
# 7
- term:
    id: GO:0004461
    label: lactose synthase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic assignment (RHEA:12404 / EC 2.4.1.22) of the lactose synthase activity
      that B4GALT1 acquires in complex with alpha-lactalbumin. Experimentally supported
      (EXP PMID:11419947, PMID:806951; IDA PMID:33805) and a core, evolutionarily selected
      bifunctional activity. Accept.
    action: ACCEPT
# 8
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic mapping from the UniProt "Secreted" keyword for the processed soluble
      form (shed catalytic domain found in milk/amniotic fluid/serum, PMID:33805). Real but
      a minor, processed-form location, not the core Golgi enzyme. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 9
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Electronic plasma-membrane mapping reflecting the cell-surface long isoform
      (PMID:1714903; PMID:3917437). A genuine but specialized/non-core pool relative to the
      Golgi catalytic function. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 10
- term:
    id: GO:0005975
    label: carbohydrate metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Very high-level InterPro-derived process term. Not wrong, but uninformative for an
      enzyme whose specific processes (protein N-linked glycosylation, lactose
      biosynthesis, glycolipid/oligosaccharide biosynthesis) are well defined and already
      annotated. Over-annotation at this generality.
    action: MARK_AS_OVER_ANNOTATED
# 11
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Electronic cell-surface mapping for the long isoform's surface pool (PMID:1714903;
      PMID:3917437). Genuine but specialized; keep as non-core.
    action: KEEP_AS_NON_CORE
# 12
- term:
    id: GO:0016757
    label: glycosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Broad InterPro grandparent term. The specific beta-1,4-galactosyltransferase
      activity (GO:0003831) is experimentally established and should supersede this generic
      term.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003831
      label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
# 13
- term:
    id: GO:0030175
    label: filopodium
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic mapping from a UniProt subcellular-location keyword associated with the
      cell-surface form. There is no direct evidence for a dedicated B4GALT1 filopodial
      function; this is an over-extension of the surface/recognition pool annotation.
    action: MARK_AS_OVER_ANNOTATED
# 14
- term:
    id: GO:0032580
    label: Golgi cisterna membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic Golgi cisterna membrane location, consistent with the trans-Golgi
      cisternal residence demonstrated by immuno-EM (PMID:6121819). Correct and specific;
      accept as a core location.
    action: ACCEPT
# 15
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: located_in
  review:
    summary: >-
      Ensembl-Compara orthology-based Golgi apparatus location, redundant with the IBA/IDA
      Golgi annotations. Correct core compartment. Accept.
    action: ACCEPT
# 16
- term:
    id: GO:0008378
    label: galactosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: enables
  review:
    summary: >-
      Parent term (galactosyltransferase activity) inferred by orthology. The specific
      beta-1,4-galactosyltransferase activity is experimentally established; modify to the
      specific child.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003831
      label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
# 17
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: part_of
  review:
    summary: >-
      Uninformative top-level complex term inferred by orthology. The biologically
      meaningful complex for B4GALT1 is the lactose synthase complex (with LALBA); there is
      also the homodimer/tubulin association (PMID:7744867). No specific GO CC term for the
      lactose synthase complex currently exists (see proposed_new_terms), so this generic
      term should be treated as an over-annotation rather than left as is.
    action: MARK_AS_OVER_ANNOTATED
# 18
- term:
    id: GO:0005989
    label: lactose biosynthetic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5653890
  qualifier: involved_in
  review:
    summary: >-
      Reactome traceable annotation for lactose synthesis. B4GALT1, in the lactose synthase
      complex, is the catalytic component producing lactose in lactating mammary gland
      (PMID:11419947; PMID:806951). This is a genuine, tissue-specific core process. Accept.
    action: ACCEPT
# 19
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656230
  qualifier: enables
  review:
    summary: >-
      Reactome reaction ("Defective B4GALT1 does not transfer Gal to the keratan chain")
      annotating the core galactosyltransferase activity (here in the keratan sulfate
      context). Correct core MF. Accept.
    action: ACCEPT
# 20
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4793956
  qualifier: enables
  review:
    summary: >-
      Reactome reaction ("Defective B4GALT1 does not add Gal to N-glycan") annotating the
      core N-glycan galactosyltransferase activity. Correct core MF. Accept.
    action: ACCEPT
# 21
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9035949
  qualifier: enables
  review:
    summary: >-
      Reactome reaction annotating the core galactosyltransferase activity (N-glycan
      precursor context). Redundant with the other MF annotations; correct. Accept.
    action: ACCEPT
# 22
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9035950
  qualifier: enables
  review:
    summary: >-
      Reactome reaction annotating the core galactosyltransferase activity (keratan branch
      context). Correct core MF. Accept.
    action: ACCEPT
# 23
- term:
    id: GO:0004461
    label: lactose synthase activity
  evidence_type: EXP
  original_reference_id: PMID:11419947
  qualifier: enables
  review:
    summary: >-
      Direct experimental support: crystal structures of the lactose synthase complex
      (beta4Gal-T1 + alpha-lactalbumin) showing alpha-lactalbumin switches acceptor
      specificity to glucose to make lactose. Core bifunctional activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:11419947
      supporting_text: >-
        The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component,
        beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component,
        alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the
        binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor
        specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to
        synthesize lactose
# 24
- term:
    id: GO:0004461
    label: lactose synthase activity
  evidence_type: EXP
  original_reference_id: PMID:806951
  qualifier: enables
  review:
    summary: >-
      Experimental support for lactose synthase activity (lactose biosynthesis review/
      primary work). Concordant with the structural and biochemical evidence; core. Accept.
    action: ACCEPT
# 25
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Human Protein Atlas immunofluorescence (IDA) localizing B4GALT1 to the Golgi
      apparatus. Concordant with all other localization evidence. Core. Accept.
    action: ACCEPT
# 26
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: EXP
  original_reference_id: PMID:29133956
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration of B4GALT1 galactosylation in the IgG glycosylation
      pathway (network inference plus enzymatic validation). Supports the core MF on
      complex N-glycans. Accept.
    action: ACCEPT
# 27
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: EXP
  original_reference_id: PMID:37632720
  qualifier: enables
  review:
    summary: >-
      Experimental use of B4GALT1 to galactosylate defined IgG N-glycans in a synthetic
      glycan library. Direct support for the core galactosyltransferase activity on
      N-glycan acceptors. Accept.
    action: ACCEPT
# 28
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: EXP
  original_reference_id: PMID:38321209
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration of B4GALT1 galactosyltransferase activity in an
      immobilized enzyme cascade for targeted N-glycosylation. Core MF. Accept.
    action: ACCEPT
# 29
- term:
    id: GO:0003945
    label: N-acetyllactosamine synthase activity
  evidence_type: EXP
  original_reference_id: PMID:16157350
  qualifier: enables
  review:
    summary: >-
      Crystallographic and kinetic study of human beta4Gal-T1 with GlcNAc-containing
      acceptors, directly demonstrating transfer of Gal to GlcNAc (LacNAc synthesis) and
      branch specificity. Core MF. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:16157350
      supporting_text: >-
        beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from
        UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked
        oligosaccharide chains of glycoproteins
# 30
- term:
    id: GO:0004461
    label: lactose synthase activity
  evidence_type: EXP
  original_reference_id: PMID:16157350
  qualifier: enables
  review:
    summary: >-
      Same structural/kinetic study addressing the acceptor specificity that underlies
      lactose synthase activity (EC 2.4.1.22 listed in UniProt with this PMID as evidence).
      Core bifunctional activity. Accept.
    action: ACCEPT
# 31
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: NAS
  original_reference_id: PMID:2120039
  qualifier: located_in
  review:
    summary: >-
      Non-traceable author statement; this paper engineered/secreted a soluble form of the
      enzyme in E. coli for substrate-site mapping, consistent with the known soluble shed
      form found extracellularly (PMID:33805). Minor processed-form location; keep as
      non-core.
    action: KEEP_AS_NON_CORE
# 32
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: EXP
  original_reference_id: PMID:1714903
  qualifier: located_in
  review:
    summary: >-
      Experimental evidence that the long isoform (extra 13-aa N-terminal cytoplasmic
      peptide) is preferentially targeted to the plasma membrane, distinct from the Golgi
      short form. A genuine but specialized surface pool; keep as non-core.
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:1714903
      supporting_text: >-
        the longer GalTase protein, containing this unique 13-amino acid peptide, is
        preferentially targeted to the plasma membrane, and the shorter GalTase protein
        resides primarily within the Golgi compartment
# 33
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: EXP
  original_reference_id: PMID:1714903
  qualifier: located_in
  review:
    summary: >-
      Same study supporting the surface-targeted long isoform. Surface pool is specialized
      (cell-cell/cell-matrix recognition), not the core catalytic compartment. Keep as
      non-core.
    action: KEEP_AS_NON_CORE
# 34
- term:
    id: GO:0061755
    label: positive regulation of circulating fibrinogen levels
  evidence_type: IMP
  original_reference_id: PMID:34855475
  qualifier: involved_in
  review:
    summary: >-
      Based on the hypomorphic p.Asn352Ser allele that lowers plasma fibrinogen by reducing
      fibrinogen N-glycan galactosylation/sialylation. This is a downstream, indirect
      physiological consequence of reduced core galactosyltransferase activity, not a
      dedicated regulatory process of B4GALT1. Keep as non-core (the underlying mechanism is
      the core MF, already captured).
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:34855475
      supporting_text: >-
        The mutant protein had 50% lower galactosyltransferase activity compared with the
        wild-type protein. N-linked glycan profiling of human serum found serine 352 allele
        to be associated with decreased galactosylation and sialylation of apolipoprotein
        B100, fibrinogen, immunoglobulin G, and transferrin
# 35
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IMP
  original_reference_id: PMID:34855475
  qualifier: involved_in
  review:
    summary: >-
      Derived from the same allele's effect on LDL-cholesterol, via reduced galactosylation
      of ApoB100 (a glycoprotein), an indirect/downstream consequence. B4GALT1 is a
      glycosyltransferase, not a lipid-metabolic enzyme; the lipid phenotype is a secondary
      effect of altered glycoprotein glycosylation. Over-annotation as a direct process.
    action: MARK_AS_OVER_ANNOTATED
    supported_by:
    - reference_id: file:human/B4GALT1/B4GALT1-deep-research-falcon.md
      supporting_text: >-
        The reviewed literature supports protein N-glycosylation and galactosylation as core
        constitutive functions, while roles in cancer cell migration, apoptosis, and
        inflammatory signaling represent context-specific, pleiotropic consequences
# 36
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IMP
  original_reference_id: PMID:34855475
  qualifier: enables
  review:
    summary: >-
      The p.Asn352Ser mutant shows ~50% reduced galactosyltransferase activity, providing
      mutant-phenotype support that B4GALT1 enables this activity. Core MF. Accept.
    action: ACCEPT
# 37
- term:
    id: GO:0035250
    label: UDP-galactosyltransferase activity
  evidence_type: IMP
  original_reference_id: PMID:34855475
  qualifier: enables
  review:
    summary: >-
      Parent-level term (UDP-galactosyltransferase activity). The specific
      beta-1,4-galactosyltransferase activity is the experimentally established function;
      modify to the specific child.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003831
      label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
# 38
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:27872474
  qualifier: enables
  review:
    summary: >-
      Direct assay: B4GALT1 used to galactosylate IgG Fc N-glycans in a glyco-engineering
      study. Supports the core MF. Accept.
    action: ACCEPT
# 39
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IDA
  original_reference_id: PMID:7744867
  qualifier: located_in
  review:
    summary: >-
      Direct localization plus mechanism: transmembrane-domain-dependent homodimerization
      and tubulin association mediate Golgi retention. Core Golgi location. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:7744867
      supporting_text: >-
        beta-1,4-galactosyltransferase
        (GT) forms homodimers and large oligomers in vivo
# 40
- term:
    id: GO:0030667
    label: secretory granule membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798743
  qualifier: located_in
  review:
    summary: >-
      Reactome neutrophil-degranulation pathway annotation. Reflects presence of B4GALT1 in
      granule-membrane proteomes during exocytosis rather than a core functional location.
      Keep as non-core.
    action: KEEP_AS_NON_CORE
# 41
- term:
    id: GO:0035577
    label: azurophil granule membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798739
  qualifier: located_in
  review:
    summary: >-
      Reactome neutrophil azurophil-granule annotation, from large-scale granule proteomics.
      Not a core functional compartment for the galactosyltransferase. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 42
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  qualifier: located_in
  review:
    summary: >-
      High-throughput exosome proteomics (prostatic secretions). Consistent with the shed/
      secreted soluble form, but exosome detection is a common high-throughput finding and
      not the core Golgi location. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 43
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: >-
      Trivial "membrane" location from an NK-cell membrane-proteome dataset. The protein is
      a single-pass membrane enzyme so "membrane" is true but uninformative; the specific
      Golgi membrane terms supersede it. Over-annotation.
    action: MARK_AS_OVER_ANNOTATED
# 44
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: HDA
  original_reference_id: PMID:16502470
  qualifier: located_in
  review:
    summary: >-
      Detection in human colostrum proteome (high-throughput). Consistent with the soluble
      secreted form in milk (PMID:33805); a minor processed-form location, not core. Keep as
      non-core.
    action: KEEP_AS_NON_CORE
# 45
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:16157350
  qualifier: enables
  review:
    summary: >-
      Direct crystallographic + kinetic demonstration of Gal transfer from UDP-Gal to
      GlcNAc on N-glycan acceptors, with branch specificity. The single best primary
      evidence for the core MF. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:16157350
      supporting_text: >-
        the K(m) of 1,2-1,6-arm is approximately tenfold lower than for
        1,2-1,3-arm and 1,4-1,3-arm
# 46
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IDA
  original_reference_id: PMID:16157350
  qualifier: involved_in
  review:
    summary: >-
      Direct-assay support for B4GALT1's role in N-glycan maturation (galactosylation of
      N-glycan antennae). Core process. Accept.
    action: ACCEPT
# 47
- term:
    id: GO:0030145
    label: manganese ion binding
  evidence_type: IDA
  original_reference_id: PMID:16157350
  qualifier: enables
  review:
    summary: >-
      B4GALT1 is a metal-dependent GT-A fold glycosyltransferase crystallized with Mn2+ in
      the active site; Mn2+ is required for catalysis. Direct, core cofactor-binding
      function. Accept.
    action: ACCEPT
# 48
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19199708
  qualifier: located_in
  review:
    summary: >-
      High-throughput parotid exosome proteomics. As with the other exosome detections, a
      non-core location consistent with the secreted/shed form. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 49
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19056867
  qualifier: located_in
  review:
    summary: >-
      High-throughput urinary exosome proteomics. Non-core location (secreted/shed form).
      Keep as non-core.
    action: KEEP_AS_NON_CORE
# 50
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656230
  qualifier: located_in
  review:
    summary: >-
      Reactome places the (defective) keratan-galactosylation reaction at the Golgi
      membrane. Correct core location. Accept.
    action: ACCEPT
# 51
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4793956
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location for the N-glycan galactosylation reaction. Correct
      core location. Accept.
    action: ACCEPT
# 52
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9035949
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location (N-glycan precursor reaction). Correct core
      location, redundant with the other Golgi membrane annotations. Accept.
    action: ACCEPT
# 53
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9035950
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location (keratan branch reaction). Correct core location.
      Accept.
    action: ACCEPT
# 54
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1297338
  qualifier: located_in
  review:
    summary: >-
      Reactome annotation for "Association of ADAM and B4GALT1 With ZP3" (fertilization /
      sperm-egg binding), placing the surface form at the plasma membrane. Reflects the
      specialized cell-surface recognition role of the long isoform. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 55
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798739
  qualifier: located_in
  review:
    summary: >-
      Reactome neutrophil-degranulation pathway (plasma-membrane fusion of azurophil
      granules). Non-core trafficking location. Keep as non-core.
    action: KEEP_AS_NON_CORE
# 56
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798743
  qualifier: located_in
  review:
    summary: >-
      Reactome secretory-granule exocytosis pathway. Non-core trafficking location. Keep as
      non-core.
    action: KEEP_AS_NON_CORE
# 57
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2025723
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location ("B4GALTs transfer Gal to the N-glycan precursor").
      Correct core location. Accept.
    action: ACCEPT
# 58
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2046265
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location ("B4GALTs transfer Gal to the keratan chain").
      Correct core location. Accept.
    action: ACCEPT
# 59
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2046298
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location ("B4GALTs transfer Gal to a branch of keratan").
      Correct core location. Accept.
    action: ACCEPT
# 60
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5653878
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location for "B4GALT1:LALBA transfers Gal from UDP-Gal to Glc
      to form Lac" (lactose synthesis occurs in the Golgi). Correct core location. Accept.
    action: ACCEPT
# 61
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5653886
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location for "B4GALT1 binds LALBA". Correct core location
      (lactose synthase assembly in the Golgi). Accept.
    action: ACCEPT
# 62
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-975919
  qualifier: located_in
  review:
    summary: >-
      Reactome Golgi membrane location ("Addition of galactose by beta 4-galactosyltransferases").
      Correct core location. Accept.
    action: ACCEPT
# 63
- term:
    id: GO:0003945
    label: N-acetyllactosamine synthase activity
  evidence_type: IDA
  original_reference_id: PMID:2120039
  qualifier: enables
  review:
    summary: >-
      Protein-engineering/mutagenesis study of recombinant human galactosyltransferase
      mapping the GlcNAc and UDP-Gal binding residues (Tyr284, Tyr309, Trp310). Directly
      supports the core LacNAc-synthase activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:2120039
      supporting_text: >-
        Tyr284, Tyr309 and Trp310 are critically involved in the
        N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as
        well
# 64
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IDA
  original_reference_id: PMID:10900002
  qualifier: located_in
  review:
    summary: >-
      Immunolocalization study (Weibel-Palade bodies / endothelial cells) using B4GALT1 as
      a Golgi marker; supports Golgi localization. Core location. Accept.
    action: ACCEPT
# 65
- term:
    id: GO:0009312
    label: oligosaccharide biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:2120039
  qualifier: involved_in
  review:
    summary: >-
      Process annotation for oligosaccharide (LacNAc) biosynthesis. Not wrong, but
      relatively general; the specific processes (protein N-linked glycosylation, lactose
      biosynthesis, glycosphingolipid biosynthesis) are better captured by more precise
      terms. Keep as non-core (broad correct process).
    action: KEEP_AS_NON_CORE
# 66
- term:
    id: GO:0000138
    label: Golgi trans cisterna
  evidence_type: IDA
  original_reference_id: PMID:6121819
  qualifier: located_in
  review:
    summary: >-
      Immuno-EM directly localizing galactosyltransferase to two-to-three trans cisternae
      of the Golgi, codistributing with thiamine pyrophosphatase. This is the most specific,
      experimentally supported core sub-Golgi location. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:6121819
      supporting_text: >-
        Label by gold particles was limited to two to three trans cisternae of the Golgi
        apparatus
# 67
- term:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:33805
  qualifier: enables
  review:
    summary: >-
      Purified soluble human galactosyltransferase from milk/amniotic fluid/ascites shows
      Gal transfer to GlcNAc/glycoprotein acceptors. Direct support for the core MF (the
      soluble form retains activity). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:33805
      supporting_text: >-
        UDP-galactose: N-acetylglucosamine galactosyltransferase was isolated from
        pooled human milk, pooled amniotic fluid and from two different individual
        samples of malignant ascites
# 68
- term:
    id: GO:0003945
    label: N-acetyllactosamine synthase activity
  evidence_type: IDA
  original_reference_id: PMID:33805
  qualifier: enables
  review:
    summary: >-
      Same purified enzyme assayed with free N-acetylglucosamine acceptor (LacNAc
      synthesis). Direct support for the core LacNAc-synthase facet. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:33805
      supporting_text: >-
        All enzyme forms showed similar activity when free
        N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and
        glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
# 69
- term:
    id: GO:0004461
    label: lactose synthase activity
  evidence_type: IDA
  original_reference_id: PMID:33805
  qualifier: enables
  review:
    summary: >-
      Same enzyme assayed with glucose acceptor in the presence of alpha-lactalbumin
      (lactose synthase activity). Direct support for the core bifunctional activity.
      Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:33805
      supporting_text: >-
        glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
# 70
- term:
    id: GO:0009897
    label: external side of plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:3917437
  qualifier: located_in
  review:
    summary: >-
      Immuno-EM of human duodenal enterocytes showing ecto-galactosyltransferase
      preferentially oriented to the outer surface of the plasma membrane. Genuine surface
      (ecto) pool; specialized/non-core relative to the Golgi catalytic role. Keep as
      non-core.
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:3917437
      supporting_text: >-
        Quantitative evaluation of the
        distribution of gold-particle label proved its preferential orientation to the
        outer surface of the plasma membrane
# 71
- term:
    id: GO:0016323
    label: basolateral plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:3917437
  qualifier: located_in
  review:
    summary: >-
      Same study: basolateral/lateral membrane labeling of enterocytes, with a proposed
      adhesion role. Surface pool; non-core.
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:3917437
      supporting_text: >-
        a role in adhesion appears
        possible on the basolateral plasma membrane
# 72
- term:
    id: GO:0030057
    label: desmosome
  evidence_type: IDA
  original_reference_id: PMID:3917437
  qualifier: located_in
  review:
    summary: >-
      Labeling near junctional complexes in enterocytes. This is incidental immuno-EM
      localization of the surface pool to junctional regions, not evidence of a dedicated
      desmosomal function of B4GALT1. Over-annotation.
    action: MARK_AS_OVER_ANNOTATED
# 73
- term:
    id: GO:0031526
    label: brush border membrane
  evidence_type: IDA
  original_reference_id: PMID:3917437
  qualifier: located_in
  review:
    summary: >-
      Intense brush-border-membrane labeling of absorptive enterocytes (ecto-GalT). A
      genuine apical surface pool in this cell type; specialized/non-core. Keep as
      non-core.
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:3917437
      supporting_text: >-
        the most intense labeling appearing
        along the brush border membrane
# 74
- term:
    id: GO:0035250
    label: UDP-galactosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:3917437
  qualifier: enables
  review:
    summary: >-
      Parent-level activity term inferred from ecto-GalT enzymatic detection. The specific
      beta-1,4-galactosyltransferase activity is established; modify to the specific child.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003831
      label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
# 75
- term:
    id: GO:0009312
    label: oligosaccharide biosynthetic process
  evidence_type: NAS
  original_reference_id: PMID:7540104
  qualifier: involved_in
  review:
    summary: >-
      Non-traceable author statement (cDNA cloning paper). Broad but correct process; the
      specific glycosylation/lactose processes are better captured elsewhere. Keep as
      non-core (general correct process).
    action: KEEP_AS_NON_CORE
# 76
- term:
    id: GO:0008378
    label: galactosyltransferase activity
  evidence_type: NAS
  original_reference_id: PMID:7540104
  qualifier: enables
  review:
    summary: >-
      Parent term from a cDNA-cloning NAS annotation. Replace with the specific
      experimentally established beta-1,4-galactosyltransferase activity.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003831
      label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10900002
  title: Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of
    human endothelial cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Endothelial localization study that uses B4GALT1 as a Golgi marker; supports the
      Golgi-apparatus IDA annotation but is otherwise about a fucosyltransferase. Low
      relevance to B4GALT1's own function.
- id: PMID:11419947
  title: Crystal structure of lactose synthase reveals a large conformational change
    in its catalytic component, the beta1,4-galactosyltransferase-I.
  findings:
  - statement: >-
      Lactose synthase is a 1:1 complex of beta4Gal-T1 (catalytic) and alpha-lactalbumin
      (regulatory); alpha-lactalbumin promotes glucose binding and switches acceptor
      specificity from GlcNAc to glucose, enabling lactose synthesis.
    supporting_text: >-
      The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component,
      beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component,
      alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the
      binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor
      specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to
      synthesize lactose
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary structural study. Directly supports the lactose synthase
      activity (EXP) and the regulatory mechanism of the B4GALT1:LALBA complex.
      Abstract-only in cache; supporting_text is a verbatim quote from the abstract.
- id: PMID:16157350
  title: 'Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal
    structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a
    pentasaccharide and trisaccharides of the N-glycan moiety.'
  findings:
  - statement: >-
      Human beta4Gal-T1 transfers Gal from UDP-Gal to terminal GlcNAc of branched
      N-glycan chains, with preference for the 1,2-1,6-arm GlcNAc.
    supporting_text: >-
      beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from
      UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked
      oligosaccharide chains of glycoproteins
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary crystallographic/kinetic study; the single best primary
      evidence for the core galactosyltransferase activity, Mn2+ cofactor requirement,
      and N-glycan branch specificity. Abstract-only in cache; quotes are verbatim from
      the abstract.
- id: PMID:16502470
  title: 'Human colostrum: identification of minor proteins in the aqueous phase by
    proteomics.'
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput colostrum proteomics; supports detection of the soluble secreted
      form in milk (extracellular-region location) but not the core function.
- id: PMID:1714903
  title: Evidence for a molecular distinction between Golgi and cell surface forms
    of beta 1,4-galactosyltransferase.
  findings:
  - statement: >-
      The longer isoform with a 13-aa N-terminal cytoplasmic extension is preferentially
      targeted to the plasma membrane; the shorter isoform resides in the Golgi.
    supporting_text: >-
      the longer GalTase protein, containing this unique 13-amino acid peptide, is
      preferentially targeted to the plasma membrane, and the shorter GalTase protein
      resides primarily within the Golgi compartment
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary study establishing the two-isoform (Golgi vs cell-surface)
      model that underpins the plasma-membrane and cell-surface annotations.
      Abstract-only in cache; quote is verbatim.
- id: PMID:19056867
  title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput urinary exosome proteomics; basis of an extracellular-exosome
      HDA location, non-core.
- id: PMID:19199708
  title: Proteomic analysis of human parotid gland exosomes by multidimensional protein
    identification technology (MudPIT).
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput parotid exosome proteomics; basis of an extracellular-exosome HDA
      location, non-core.
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput NK-cell membrane proteome; basis of a trivial "membrane" HDA
      location.
- id: PMID:2120039
  title: Analysis of the substrate binding sites of human galactosyltransferase by
    protein engineering.
  findings:
  - statement: >-
      Mutagenesis of recombinant human galactosyltransferase identifies Tyr284, Tyr309
      and Trp310 as critical for GlcNAc binding, and Tyr309 for UDP-galactose binding.
    supporting_text: >-
      Tyr284, Tyr309 and Trp310 are critically involved in the
      N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as
      well
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary protein-engineering study mapping substrate-binding
      residues; supports the LacNAc-synthase MF and oligosaccharide-biosynthesis
      annotations. Note the active-site residues here (Tyr284/Tyr309/Trp310) are the
      verified ones, not the Arg187/Glu313 quoted by the Falcon report.
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
    secretions in urine.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput prostatic-secretion exosome proteomics; basis of an
      extracellular-exosome HDA location, non-core.
- id: PMID:27872474
  title: Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.
  findings:
  - statement: >-
      B4GALT1 is used to galactosylate IgG Fc N-glycans; galactosylation level can be
      modulated by glyco-engineering, supporting the enzyme's role in complex N-glycan
      galactosylation.
    supporting_text: >-
      glycosyltransferases were transiently overexpressed to enhance bisection,
      galactosylation and sialylation
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified; full text available in cache. Supports the IDA
      galactosyltransferase activity on IgG Fc N-glycans (the abstract speaks at the
      glyco-engineering level; the GOA IDA reflects the enzyme's role in the workflow).
- id: PMID:29133956
  title: Network inference from glycoproteomics data reveals new reactions in the
    IgG glycosylation pathway.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified; supports the EXP beta-1,4-galactosyltransferase activity in the IgG
      N-glycosylation pathway. Used by UniProt as evidence for EC 2.4.1.38.
- id: PMID:33805
  title: The charge heterogeneity of soluble human galactosyltransferases isolated
    from milk, amniotic fluid and malignant ascites.
  findings:
  - statement: >-
      Soluble human UDP-galactose:GlcNAc galactosyltransferase purified from milk,
      amniotic fluid and ascites is active on free GlcNAc, glycoprotein acceptors and on
      glucose in the presence of alpha-lactalbumin.
    supporting_text: >-
      All enzyme forms showed similar activity when free
      N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and
      glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
  - statement: >-
      The enzyme exists as a soluble shed form in body fluids.
    supporting_text: >-
      UDP-galactose: N-acetylglucosamine galactosyltransferase was isolated from
      pooled human milk, pooled amniotic fluid and from two different individual
      samples of malignant ascites
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary biochemistry; supports the IDA MF annotations
      (beta-1,4-GalT, LacNAc synthase, lactose synthase) on the purified soluble enzyme
      and explains the extracellular/secreted-form locations. Abstract-only in cache;
      quotes verbatim.
- id: PMID:34855475
  title: Genetic and functional evidence links a missense variant in B4GALT1 to lower
    LDL and fibrinogen.
  findings:
  - statement: >-
      The hypomorphic p.Asn352Ser allele halves galactosyltransferase activity and lowers
      serum LDL-C and fibrinogen by reducing galactosylation/sialylation of ApoB100,
      fibrinogen, IgG and transferrin.
    supporting_text: >-
      The mutant protein had 50% lower galactosyltransferase activity compared with the
      wild-type protein. N-linked glycan profiling of human serum found serine 352 allele
      to be associated with decreased galactosylation and sialylation of apolipoprotein
      B100, fibrinogen, immunoglobulin G, and transferrin
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified Science paper. Supports the IMP MF (reduced GalT activity) and shows
      the fibrinogen/lipid phenotypes are downstream consequences of reduced glycoprotein
      galactosylation, hence the non-core / over-annotation calls for the BP annotations.
- id: PMID:37632720
  title: Divergent Enzymatic Assembly of a Comprehensive 64-Membered IgG N-Glycan
    Library for Functional Glycomics.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified; B4GALT1 used to add Gal to defined IgG N-glycans, supporting the
      EXP galactosyltransferase activity. UniProt evidence for EC 2.4.1.38.
- id: PMID:38321209
  title: Immobilized enzyme cascade for targeted glycosylation.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified; B4GALT1 used in an immobilized cascade to galactosylate N-glycans,
      supporting the EXP galactosyltransferase activity. UniProt evidence for EC 2.4.1.38.
- id: PMID:3917437
  title: Immunocytochemical demonstration of ecto-galactosyltransferase in absorptive
    intestinal cells.
  findings:
  - statement: >-
      Ecto-galactosyltransferase is present on the plasma membrane of human duodenal
      enterocytes, most intensely on the brush border, oriented to the outer surface, with
      a possible adhesion role basolaterally.
    supporting_text: >-
      Antigenic sites detected
      with affinity-purified, monospecific antibodies were found at the plasma
      membrane of absorptive enterocytes with the most intense labeling appearing
      along the brush border membrane
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary immuno-EM study; supports the surface/ecto-GalT location
      annotations (external side of PM, basolateral PM, brush border, desmosome) for the
      cell-surface pool. Notes the authors' own caveat that surface GalT precludes its use
      as a generic Golgi marker.
- id: PMID:6121819
  title: 'Immunocytochemical localization of galactosyltransferase in HeLa cells:
    codistribution with thiamine pyrophosphatase in trans-Golgi cisternae.'
  findings:
  - statement: >-
      Galactosyltransferase is localized to two-to-three trans cisternae of the Golgi,
      codistributing with thiamine pyrophosphatase.
    supporting_text: >-
      Label by gold particles was limited to two to three trans cisternae of the Golgi
      apparatus
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary immuno-EM study; the most specific evidence for trans-Golgi
      cisternal localization (supports the Golgi trans cisterna IDA). Abstract-only in
      cache; quote verbatim.
- id: PMID:7540104
  title: Analysis of the sequences of human beta-1,4-galactosyltransferase cDNA clones.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified cDNA-cloning paper; basis of NAS galactosyltransferase activity and
      oligosaccharide-biosynthesis annotations. Low relevance for functional inference
      beyond confirming identity.
- id: PMID:7744867
  title: Golgi retention mechanism of beta-1,4-galactosyltransferase. Membrane-spanning
    domain-dependent homodimerization and association with alpha- and beta-tubulins.
  findings:
  - statement: >-
      B4GALT1 forms transmembrane-domain-dependent homodimers/oligomers and associates with
      alpha- and beta-tubulin, mechanisms underlying its Golgi retention.
    supporting_text: >-
      beta-1,4-galactosyltransferase
      (GT) forms homodimers and large oligomers in vivo
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary study; supports the IDA Golgi-apparatus localization and the
      homodimerization/Golgi-retention mechanism. Abstract-only in cache; quote verbatim.
- id: PMID:806951
  title: Lactose biosynthesis.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Classic lactose-biosynthesis reference; basis of the EXP lactose synthase activity,
      concordant with the structural/biochemical evidence.
- id: file:human/B4GALT1/B4GALT1-deep-research-falcon.md
  title: FutureHouse Falcon deep-research report for B4GALT1
  findings:
  - statement: >-
      Deep-research synthesis: core function is Golgi (trans-Golgi) beta-1,4-galactosylation
      of terminal GlcNAc to form LacNAc on N-glycans/glycolipids, with Mn2+ cofactor and
      UDP-Gal donor; lactose synthase (with LALBA) is a tissue-specific core function;
      reported cancer/apoptosis/inflammation roles are pleiotropic, context-specific
      consequences of altered glycosylation and not dedicated B4GALT1 processes.
    supporting_text: >-
      The reviewed literature supports protein N-glycosylation and galactosylation as core
      constitutive functions, while roles in cancer cell migration, apoptosis, and
      inflammatory signaling represent context-specific, pleiotropic consequences
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      FutureHouse Falcon deep-research report. Its high-level conclusions (core MF, Golgi
      localization, bifunctional lactose synthase, pleiotropy of disease roles) are
      concordant with the primary literature and were used for orientation. Its specific
      disease-mechanism citations use non-resolvable internal keys (not fetchable PMIDs),
      so those claims were NOT used as supporting evidence; its active-site residue numbers
      (Arg187/Glu313) conflict with the verified residues in PMID:2120039 and were rejected.
      See B4GALT1-notes.md "Falcon integration" for details.
- id: Reactome:R-HSA-1297338
  title: Association of ADAM and B4GALT1 With ZP3
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Reactome reaction for sperm-egg (ZP3) binding; basis of a plasma-membrane location
      for the surface long isoform's recognition role (non-core).
- id: Reactome:R-HSA-2025723
  title: B4GALTs transfer Gal to the N-glycan precursor
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction; supports core N-glycan galactosylation at the Golgi membrane.
- id: Reactome:R-HSA-2046265
  title: B4GALTs transfer Gal to the keratan chain
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Reactome keratan-sulfate galactosylation reaction; core MF in the keratan context.
- id: Reactome:R-HSA-2046298
  title: B4GALTs transfer Gal to a branch of keratan
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Reactome keratan-branch galactosylation reaction; core MF.
- id: Reactome:R-HSA-3656230
  title: Defective B4GALT1 does not transfer Gal to the keratan chain
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Reactome disease-variant reaction (CDG2D); annotates the core MF and Golgi membrane
      location by reference to loss of function.
- id: Reactome:R-HSA-4793956
  title: Defective B4GALT1 does not add Gal to N-glycan
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Reactome disease-variant reaction; annotates the core N-glycan galactosyltransferase
      activity and Golgi membrane location.
- id: Reactome:R-HSA-5653878
  title: B4GALT1:LALBA transfers Gal from UDP-Gal to Glc to form Lac
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reactome lactose-synthesis reaction; supports lactose synthase activity and Golgi
      membrane location of the B4GALT1:LALBA complex.
- id: Reactome:R-HSA-5653886
  title: B4GALT1 binds LALBA
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reactome reaction for assembly of the lactose synthase complex; supports the
      B4GALT1-LALBA interaction and Golgi membrane location.
- id: Reactome:R-HSA-5653890
  title: Lactose synthesis
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reactome pathway for lactose biosynthesis; supports the TAS lactose biosynthetic
      process annotation (core, mammary-specific).
- id: Reactome:R-HSA-6798739
  title: Exocytosis of azurophil granule membrane proteins
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Reactome neutrophil-degranulation reaction; basis of azurophil-granule-membrane and
      plasma-membrane locations (non-core trafficking).
- id: Reactome:R-HSA-6798743
  title: Exocytosis of secretory granule membrane proteins
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Reactome secretory-granule exocytosis reaction; basis of secretory-granule-membrane
      and plasma-membrane locations (non-core trafficking).
- id: Reactome:R-HSA-9035949
  title: Defective B4GALT1 does not transfer Gal to the N-glycan precursor
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Reactome disease-variant reaction; annotates core MF and Golgi membrane.
- id: Reactome:R-HSA-9035950
  title: Defective B4GALT1 does not transfer Gal to a branch of keratan
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Reactome disease-variant reaction; annotates core MF and Golgi membrane.
- id: Reactome:R-HSA-975919
  title: Addition of galactose by beta 4-galactosyltransferases
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reactome reaction for galactosylation by beta-4-galactosyltransferases; supports core
      MF and Golgi membrane location.
core_functions:
- description: >-
    Core catalytic function: B4GALT1 is a Mn2+-dependent, trans-Golgi-resident type II
    membrane glycosyltransferase that transfers galactose from UDP-alpha-D-galactose in a
    beta-1,4 linkage onto the non-reducing terminal N-acetylglucosamine of complex-type
    N-glycans (and of glycolipids and free GlcNAc), forming the Galbeta1-4GlcNAc (type-2
    LacNAc) unit. This is the galactosylation step of complex N-glycan maturation and the
    LacNAc-synthesis activity, requiring Mn2+ as cofactor.
  molecular_function:
    id: GO:0003831
    label: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
  directly_involved_in:
  - id: GO:0006487
    label: protein N-linked glycosylation
  locations:
  - id: GO:0000139
    label: Golgi membrane
  - id: GO:0000138
    label: Golgi trans cisterna
  substrates:
  - id: CHEBI:66914
    label: UDP-alpha-D-galactose
  supported_by:
  - reference_id: PMID:16157350
    supporting_text: >-
      beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from
      UDP-galactose to N-acetylglucosamine (GlcNAc) residues of the branched N-linked
      oligosaccharide chains of glycoproteins
  - reference_id: PMID:6121819
    supporting_text: >-
      Label by gold particles was limited to two to three trans cisternae of the Golgi
      apparatus
- description: >-
    LacNAc synthase facet of the core activity: transfer of Gal from UDP-Gal to free or
    terminal GlcNAc to form N-acetyllactosamine (Galbeta1-4GlcNAc), the universal scaffold
    for further glycan extension (poly-LacNAc, sialylation, fucosylation). Mn2+-dependent.
  molecular_function:
    id: GO:0003945
    label: N-acetyllactosamine synthase activity
  locations:
  - id: GO:0000139
    label: Golgi membrane
  supported_by:
  - reference_id: PMID:2120039
    supporting_text: >-
      Tyr284, Tyr309 and Trp310 are critically involved in the
      N-acetyglucosamine binding and Tyr309 is involved in UDP-galactose binding as
      well
  - reference_id: PMID:33805
    supporting_text: >-
      All enzyme forms showed similar activity when free
      N-acetylglucosamine, ovalbumin, sialic-acid-free ovine submaxillary mucin and
      glucose, in the presence of alpha-lactalbumin, were used as acceptor substrates
- description: >-
    Bifunctional lactose synthase activity: in the lactating mammary gland B4GALT1 forms a
    1:1 complex with alpha-lactalbumin (LALBA). alpha-Lactalbumin lowers the Km for glucose
    and switches the acceptor specificity from GlcNAc to glucose, so the complex transfers
    Gal from UDP-Gal to glucose to synthesize lactose (Galbeta1-4Glc), the major milk
    sugar. This is a tissue-specific, evolutionarily selected core function executed at the
    Golgi membrane.
  molecular_function:
    id: GO:0004461
    label: lactose synthase activity
  directly_involved_in:
  - id: GO:0005989
    label: lactose biosynthetic process
  locations:
  - id: GO:0000139
    label: Golgi membrane
  supported_by:
  - reference_id: PMID:11419947
    supporting_text: >-
      The lactose synthase (LS) enzyme is a 1:1 complex of a catalytic component,
      beta1,4-galactosyltransferse (beta4Gal-T1) and a regulatory component,
      alpha-lactalbumin (LA), a mammary gland-specific protein. LA promotes the
      binding of glucose (Glc) to beta4Gal-T1, thereby altering its sugar acceptor
      specificity from N-acetylglucosamine (GlcNAc) to glucose, which enables LS to
      synthesize lactose
- description: >-
    Cofactor binding required for catalysis: B4GALT1 is a GT-A fold, metal-dependent
    glycosyltransferase that binds Mn2+ in its active site, coordinating the UDP-Gal
    diphosphate for galactosyl transfer.
  molecular_function:
    id: GO:0030145
    label: manganese ion binding
  locations:
  - id: GO:0000139
    label: Golgi membrane
  supported_by:
  - reference_id: PMID:16157350
    supporting_text: >-
      beta-1,4-Galactosyltransferase-I (beta4Gal-T1) transfers galactose from
      UDP-galactose to N-acetylglucosamine (GlcNAc) residues
proposed_new_terms:
- proposed_name: lactose synthase complex
  proposed_definition: >-
    A heterodimeric protein-containing complex, located in the Golgi membrane of lactating
    mammary epithelial cells, composed of beta-1,4-galactosyltransferase 1 (the catalytic
    subunit) and alpha-lactalbumin (the regulatory subunit). Within this complex
    alpha-lactalbumin alters the acceptor specificity of beta-1,4-galactosyltransferase 1
    from N-acetylglucosamine to glucose, enabling the synthesis of lactose from
    UDP-galactose and glucose.
  justification: >-
    B4GALT1 has a long-established, structurally characterized obligate complex with
    alpha-lactalbumin (lactose synthase; PMID:11419947), but the only complex term applied
    in GOA is the uninformative top-level GO:0032991 (protein-containing complex). A
    specific CC term for the lactose synthase complex would let B4GALT1 (and LALBA) be
    annotated to their actual functional complex via in_complex rather than the generic
    parent.
  proposed_parent:
    id: GO:0032991
    label: protein-containing complex
  proposed_mappings:
  - predicate: skos:relatedMatch
    target_term:
      id: RHEA:12404
      label: D-glucose + UDP-alpha-D-galactose = lactose + UDP + H(+)
suggested_questions:
- question: >-
    Beyond the well-established Golgi catalytic role and the lactose synthase complex, does
    the cell-surface (long isoform) pool of B4GALT1 have a physiologically significant
    galactosyltransferase or recognition function in humans (e.g. sperm-egg ZP3 binding or
    cell-matrix adhesion), or is this largely a feature inferred from mouse orthologs?
- question: >-
    What is the relative in vivo contribution of B4GALT1 versus the other B4GALT family
    members (B4GALT2-4) to the bulk galactosylation of complex N-glycans, O-glycans,
    keratan sulfate and glycolipids in different human tissues?
suggested_experiments:
- description: >-
    Glycomic/glycoproteomic profiling of B4GALT1-knockout versus wild-type human cells
    (and rescue with catalytically dead vs wild-type B4GALT1) to quantify loss of terminal
    Galbeta1-4GlcNAc on N-glycans, O-glycans and glycolipids and to define which acceptor
    classes are most dependent on B4GALT1 versus redundant family members.
  hypothesis: >-
    B4GALT1 is the dominant but partially redundant beta-1,4-galactosyltransferase for
    complex N-glycan LacNAc formation, with acceptor-class-specific dependence.
- description: >-
    Reconstitution of the lactose synthase complex with purified B4GALT1 and LALBA,
    measuring the alpha-lactalbumin-dependent shift in acceptor Km (glucose vs GlcNAc), to
    quantify the regulatory switch and test how disease/variant residues (e.g. the
    Asn352Ser hypomorph) affect both N-glycan galactosylation and lactose synthesis.
  hypothesis: >-
    alpha-Lactalbumin binding lowers the glucose Km of B4GALT1 by orders of magnitude, and
    hypomorphic variants reduce both LacNAc and lactose synthesis proportionally to their
    effect on the shared catalytic site.
- description: >-
    Isoform-resolved localization and functional assay (CRISPR knock-in of tags on the long
    vs short B4GALT1 isoforms) in polarized epithelial cells to determine whether the
    surface long-isoform pool carries out extracellular galactosylation or acts purely as a
    non-catalytic recognition molecule.
  hypothesis: >-
    The long isoform's cell-surface pool functions chiefly in cell-surface
    recognition/adhesion rather than as a major source of extracellular galactosyltransfer.